SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------------------------------------------------------------------
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 10)
REN CORPORATION-USA
-------------------
(Name of Issuer)
Common Stock, no par value
--------------------------
(Title of Class of Securities)
7596561010
----------
(CUSIP Number)
Mats Wahlstrom
COBE Laboratories, Inc.
1185 Oak Street
Suite 500C
Lakewood, Colorado 80215
Telephone: (303) 232-6800
--------------------------
(Name, Address and Telephone Number of
Person Authorized to Receive Notices and
Communications)
Copy to:
Peter D. Lyons, Esq.
Shearman & Sterling
599 Lexington Avenue
New York, New York 10022
Telephone: (212) 848-4000
September 12, 1995
(Date of Event which Required Filing of this Statement)
---------------------------------------------------------------------------
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule
13d-1(b)(3) or (4), check the following box / /.
Check the following box if a fee is being paid with this statement / /.
<PAGE>
CUSIP No. 7596561010
(1) Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
COBE Laboratories, Inc.
----------------------------------------------------------------------
----------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group (See Instructions)
/ / (a)
-----------------------------------------------------------------
/ / (b)
-----------------------------------------------------------------
-----------------------------------------------------------------
(3) SEC Use Only
----------------------------------------------------------
----------------------------------------------------------------------
(4) Source of Funds (See Instructions) WC
------------------------------------
----------------------------------------------------------------------
(5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items
2(d) or 2(e).
----------------------------------------------------------------------
(6) Citizenship or Place of Organization Colorado
---------------------------------
----------------------------------------------------------------------
----------
Number of (7) Sole Voting Power 10,036,221
----------------------
Shares
----------------------------------------
Beneficially (8) Shared Voting Power 0
--------------------
----------------------------------------
Owned by (9) Sole Dispositive Power 10,036,221
-----------------
Each
----------------------------------------
Reporting (10) Shared Dispositive Power 0
---------------
Person
----------------------------------------
With
----------
(11) Aggregate Amount Beneficially Owned by Each Reporting
Person 10,036,221 shares of Common Stock
---------------------------------------------------------------
(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions)
---------------------------------------------------
----------------------------------------------------------------------
(13) Percent of Class Represented by Amount in Row
(11) Approximately 53%
-----------------------------------------------------------------
(14) Type of Reporting Person (See Instructions) CO
--------------------------
2
<PAGE>
CUSIP No. 7596561010
(1) Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Gambro AB
----------------------------------------------------------------------
----------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group (See Instructions)
/ / (a)
-----------------------------------------------------------------
/ / (b)
-----------------------------------------------------------------
-----------------------------------------------------------------
(3) SEC Use Only
----------------------------------------------------------
----------------------------------------------------------------------
(4) Source of Funds (See Instructions) AF
------------------------------------
----------------------------------------------------------------------
(5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items
2(d) or 2(e).
----------------------------------------------------------------------
(6) Citizenship or Place of Organization The Kingdom of Sweden
---------------------------------
----------------------------------------------------------------------
----------
Number of (7) Sole Voting Power 10,036,221
----------------------
Shares
----------------------------------------
Beneficially (8) Shared Voting Power 0
--------------------
----------------------------------------
Owned by (9) Sole Dispositive Power 10,036,221
-----------------
Each
----------------------------------------
Reporting (10) Shared Dispositive Power 0
---------------
Person
----------------------------------------
With
----------
(11) Aggregate Amount Beneficially Owned by Each Reporting
Person 10,036,221 shares of Common Stock
---------------------------------------------------------------
(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions)
---------------------------------------------------
----------------------------------------------------------------------
(13) Percent of Class Represented by Amount in Row
(11) Approximately 53%
-----------------------------------------------------------------
(14) Type of Reporting Person (See Instructions) CO
--------------------------
3
<PAGE>
CUSIP No. 7596561010
(1) Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Incentive AB
----------------------------------------------------------------------
----------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group (See Instructions)
/ / (a)
-----------------------------------------------------------------
/ / (b)
-----------------------------------------------------------------
-----------------------------------------------------------------
(3) SEC Use Only
----------------------------------------------------------
----------------------------------------------------------------------
(4) Source of Funds (See Instructions) AF
------------------------------------
----------------------------------------------------------------------
(5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items
2(d) or 2(e).
----------------------------------------------------------------------
(6) Citizenship or Place of Organization The Kingdom of Sweden
---------------------------------
----------------------------------------------------------------------
----------
Number of (7) Sole Voting Power 10,036,221
----------------------
Shares
----------------------------------------
Beneficially (8) Shared Voting Power 0
--------------------
----------------------------------------
Owned by (9) Sole Dispositive Power 10,036,221
-----------------
Each
----------------------------------------
Reporting (10) Shared Dispositive Power 0
---------------
Person
----------------------------------------
With
----------
(11) Aggregate Amount Beneficially Owned by Each Reporting
Person 10,036,221 shares of Common Stock
---------------------------------------------------------------
(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions)
---------------------------------------------------
----------------------------------------------------------------------
(13) Percent of Class Represented by Amount in Row
(11) Approximately 53%
-----------------------------------------------------------------
(14) Type of Reporting Person (See Instructions) CO
--------------------------
4
<PAGE>
CUSIP No. 7596561010
(1) Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
REN Acquisition Corp.
----------------------------------------------------------------------
----------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group (See Instructions)
/ / (a)
-----------------------------------------------------------------
/ / (b)
-----------------------------------------------------------------
-----------------------------------------------------------------
(3) SEC Use Only
----------------------------------------------------------
----------------------------------------------------------------------
(4) Source of Funds (See Instructions) AF
------------------------------------
----------------------------------------------------------------------
(5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items
2(d) or 2(e).
----------------------------------------------------------------------
(6) Citizenship or Place of Organization Tennessee
---------------------------------
----------------------------------------------------------------------
----------
Number of (7) Sole Voting Power 10,036,221
----------------------
Shares
----------------------------------------
Beneficially (8) Shared Voting Power 0
--------------------
----------------------------------------
Owned by (9) Sole Dispositive Power 10,036,221
-----------------
Each
----------------------------------------
Reporting (10) Shared Dispositive Power 0
---------------
Person
----------------------------------------
With
----------
(11) Aggregate Amount Beneficially Owned by Each Reporting
Person 10,036,221 shares of Common Stock
---------------------------------------------------------------
(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions)
---------------------------------------------------
----------------------------------------------------------------------
(13) Percent of Class Represented by Amount in Row
(11) Approximately 53%
-----------------------------------------------------------------
(14) Type of Reporting Person (See Instructions) CO
--------------------------
5
<PAGE>
Amendment No. 10 to Schedule 13D
--------------------------------
COBE Laboratories, Inc., a Colorado corporation (the
"Purchaser"), REN Acquisition Corp., a Tennessee corporation ("REN
--------- ---
Acquisition Corp."), Gambro AB, a Swedish corporation, and Incentive AB, a
-----------------
Swedish corporation, hereby amend and supplement the Statement on Schedule
13D, dated May 24, 1991 (the "Original Statement"), as amended by Amendment
------------------
No. 1 thereto dated June 5, 1991, Amendment No. 2 thereto dated February 9,
1992, Amendment No. 3 thereto dated March 17, 1992, Amendment No. 4 thereto
dated May 12, 1992, Amendment No. 5 thereto dated July 2, 1992, Amendment
No. 6 thereto dated October 1, 1992, Amendment No. 7 thereto dated April
13, 1993, Amendment No. 8 thereto dated July 15, 1993 and Amendment No. 9
thereto dated July 13, 1995 (the Original Statement, as so amended, being
the "13D Statement"), with respect to the common stock, no par value (the
-------------
"Common Stock"), of REN Corporation-USA, a Tennessee corporation (the
------------
"Issuer").
------
Unless otherwise indicated, each capitalized term used and not
defined herein shall have the meaning assigned to such term in the 13D
Statement.
Item 2. Identity and Background
------ -----------------------
Item 2 of the 13D Statement is hereby amended in its entirety to
read as follows:
"This statement is being filed by Cobe Laboratories, Inc., a
Colorado corporation ("Cobe"), REN Acquisition Corp., a Tennessee
----
corporation ("REN Acquisition Corp."), Gambro AB, a Swedish corporation
---------------------
("Gambro") and Incentive AB, a Swedish corporation ("Incentive"). Cobe,
------ ---------
REN Acquisition Corp., Gambro and Incentive are collectively referred to
herein as the "Reporting Persons". The principal executive offices of Cobe
-----------------
and REN Acquisition Corp. are located at 1185 Oak Street, Lakewood,
Colorado 80215. Cobe and its subsidiaries design, develop, manufacture,
distribute, sell and service medical and therapeutic systems for four
medical market segments: cardiovascular, renal care, apheresis and blood
banking.
REN Acquisition Corp. is a wholly owned subsidiary of Cobe and
was incorporated as a Tennessee corporation on September 9, 1995 to serve
as an acquisition vehicle in connection with the transactions contemplated
by the Merger Agreement (as defined in Item 6 below). Cobe is a direct wholly
owned subsidiary of Gambro GmbH, a German corporation, which is a direct
wholly owned subsidiary of Gambro. Gambro GmbH's principal executive
offices are located at Lochhamer Strasse 15, P.O. Box 1464, D-82143,
Planegg Martinsried, Germany. Gambro's principal executive offices are
located at P.O. Box 10101 Magistratsvagen 16, S-220 10 Lund, Sweden.
Gambro is a Swedish industrial group focusing on operations in four
business areas: Renal Care, Cardiovascular Surgery, Blood Component
Technology and Health Care Services. Incentive owns shares representing
approximately 58.4% of the total voting power of Gambro. The address of
the principal executive offices of Incentive is located at Hamngatan 2,
P.O. Box 7373, S-10391, Stockholm, Sweden.
The name, citizenship, business address and present principal
occupation of each of the directors and executive officers of Cobe, Gambro,
Incentive and REN Acquisition Corp. are set forth in, respectively,
Schedules I, II, III and IV hereto.
During the last five years, none of the Reporting Persons (nor,
to the best knowledge of the Reporting Persons, Gambro GmbH or any of the
persons listed on Schedules I, II, III and IV hereto) has been convicted in
a criminal proceeding (excluding traffic violations or similar
misdemeanors) or been a party to a civil proceeding of a judicial or
administrative body of competent
6
<PAGE>
jurisdiction and as a result of such proceeding was or is subject
to a judgment, decree or final order enjoining future violations of, or
prohibiting or mandating activities subject to, United States federal or
state securities laws or finding any violation with respect to such laws."
Item 4. Purpose of Transaction
------- ----------------------
Item 6. Contracts, Arrangements, Understandings or
------- ------------------------------------------
Relationships with Respect to Securities of the Issuer
------------------------------------------------------
Items 4 and 6 of the 13D Statement are hereby amended and
supplemented by adding the following to the end thereof:
"In accordance with Section 5.11 of the Stock Purchase Agreement,
on September 12, 1995, the Board of the Issuer delivered to the Purchaser a
letter (the "Offer Request Letter"), substantially in the form of Exhibit R
-----------------------
hereto, requesting Gambro, Purchaser and REN Acquisition Corp. to enter
into the Agreement and Plan of Merger dated as of September 12, 1995 (the
"Merger Agreement"), among the Issuer and Gambro, Purchaser and REN
-------------------
Acquisition Corp., and to consummate the transactions contemplated thereby
including, without limitation, the Offer and the Merger (as such terms are
defined in the Merger Agreement). The Merger Agreement is attached hereto
as Exhibit S and is incorporated herein by reference in its entirety.
On September 13, 1995, the Issuer issued a press release relating
to the events described above. Such press release is attached hereto as
Exhibit T and is incorporated herein by reference in its entirety.
Except as set forth herein, the Purchaser and its affiliates have
not formulated any plans or proposals which relate to or would result in:
(a) the acquisition by any person of additional securities of the Issuer or
the disposition of securities of the Issuer, (b) an extraordinary corporate
transaction, such as a merger, reorganization or liquidation, involving the
Issuer or any of its subsidiaries, (c) a sale or transfer of a material
amount of the assets of the Issuer or any of its subsidiaries, (d) any
change in the present Board or management of the Issuer, including any
plans or proposals to change the number or term of directors or to fill any
existing vacancies on the Board, (e) any material change in the Issuer's
business or corporate structure, (f) any change in the Issuer's certificate
of incorporation or by-laws or other instrument corresponding thereto or
other action which may impede the acquisition of control of the Issuer by
any person, (g) causing a class of the Issuer's securities to be
deregistered or delisted, (h) a class of equity securities of the Issuer
becoming eligible for termination of registration or (i) any action similar
to any of those enumerated above."
Item 7. Items to be Filed as Exhibits
-----------------------------
Item 7 of the 13D Statement is hereby amended and supplemented by
adding the following Exhibits to the end thereof:
"Exhibit Description
------- -----------
R Offer Request Letter, dated as of September
12, 1995, from the Board of the Issuer
addressed to the Purchaser.
7
<PAGE>
S Agreement and Plan of Merger, dated as of
September 12, 1995 (the "Merger Agreement"),
-------------------
among the Issuer and Gambro, the Purchaser and REN
Acquisition Corp.
T Press Release issued by the Issuer on
September 13, 1995."
8
<PAGE>
SIGNATURE
---------
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated: September 13, 1995
COBE LABORATORIES, INC.
By:
-----------------------
Name: Herbert S. Lawson
Title: Chief Financial Officer
9
<PAGE>
SIGNATURE
---------
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated: September 13, 1995
GAMBRO AB
By:
--------------------
Name: Berthold Lindqvist
Title: President
10
<PAGE>
SIGNATURE
---------
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated: September 13, 1995
INCENTIVE AB
By:
--------------------
Name: Mikael Lilius
Title: President
11
<PAGE>
SIGNATURE
---------
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated: September 13, 1995
REN ACQUISITION CORP.
By:
--------------------
Name: Ralph Z. Levy, Jr.
Title: Vice President
12
<PAGE>
SCHEDULE I
DIRECTORS AND EXECUTIVE OFFICERS OF COBE LABORATORIES, INC.
-----------------------------------------------------------
PRESENT PRINCIPAL OCCUPATION OR EMPLOYMENT,
INCLUDING NAME, PRINCIPAL BUSINESS AND
NAME, BUSINESS ADDRESS ADDRESS OF SUCH CORPORATION OR ORGANIZATION
AND CITIZENSHIP* (OTHER THAN COBE LABORATORIES, INC.)
------------------------------- -----------------------------------------
DIRECTORS OF COBE LABORATORIES, INC.
------------------------------------
Randall F. Bellows Retired Executive Vice President of COBE
Laboratories, Inc.; Private Investor.
Robert M. Collins Retired President of COBE Laboratories, Inc.;
Private Investor.
Edward J. Giachetti Vice President of COBE Laboratories, Inc. and
President of COBE Cardiovascular, Inc.
Alain Granger (France) President of Hospal AG, Hospal S.A., 188 Av.
Jean-Jaures, F-69007, Lyon, France.
Ugo Grondelli (Italy) Senior Executive Vice President and Deputy
Managing Director of Gambro AB and President
of Gambro SpA., Via Aldo Moro I/A, I-43035,
Felino (PR), Italy.
Jan Gustavsson (Sweden) Chief Financial Officer of Gambro AB, Box
10101, S-220 10 Lund, Sweden.
Berthold Lindqvist (Sweden) President and Chief Executive Officer of
Gambro AB, Box 10101, S-220 10 Lund, Sweden.
Ingmar Magnusson (Sweden) General Counsel of Gambro AB, Box 10101, S-
220 10 Lund, Sweden.
Mats Wahlstrom (Sweden) President of COBE Laboratories, Inc.;
Executive Vice President of Gambro AB;
Director, Chairman of the Board, President,
Assistant Secretary and Assistant Treasurer
of REN Acquisition Corp.
Edward C. Wood, Jr. President of COBE BCT, Inc., 1201 Oak Street,
Lakewood, CO 80215-4498.
--------------------
* Unless otherwise indicated, the business address of each of the named
persons is 1185 Oak Street, Lakewood, Colorado 80215. Each person
listed above, unless otherwise indicated, is a citizen of the U.S.A.
13
<PAGE>
DIRECTORS AND EXECUTIVE OFFICERS OF COBE LABORATORIES, INC.
-----------------------------------------------------------
PRESENT PRINCIPAL OCCUPATION OR EMPLOYMENT,
INCLUDING NAME, PRINCIPAL BUSINESS AND
NAME, BUSINESS ADDRESS ADDRESS OF SUCH CORPORATION OR ORGANIZATION
AND CITIZENSHIP* (OTHER THAN COBE LABORATORIES, INC.)
---------------------- -----------------------------------------
EXECUTIVE OFFICERS OF COBE LABORATORIES, INC.
---------------------------------------------
Teresa Blandford Vice President of COBE Laboratories, Inc.
Wendell J. Gardner Senior Vice President.
Edward J. Giachetti Vice President of COBE Laboratories, Inc. and
President of COBE Cardiovascular, Inc.
Herbert S. Lawson Vice President, Chief Financial Officer,
Treasurer and Assistant Secretary of COBE
Laboratories, Inc.; Director, Vice President,
Treasurer and Assistant Secretary of REN
Acquisition Corp.
Curtin L. Wagner Vice President of COBE Laboratories, Inc.
Mats Wahlstrom (Sweden) President of COBE Laboratories, Inc.
--------------------
* Unless otherwise indicated, the business address of each of the named
persons is 1185 Oak Street, Lakewood, Colorado 80215. Each person
listed above, unless otherwise indicated, is a citizen of the U.S.A.
14
<PAGE>
SCHEDULE II
DIRECTORS AND EXECUTIVE OFFICERS OF GAMBRO AB
---------------------------------------------
PRESENT PRINCIPAL OCCUPATION OR EMPLOYMENT,
INCLUDING NAME, PRINCIPAL BUSINESS AND
NAME, BUSINESS ADDRESS ADDRESS OF SUCH CORPORATION OR ORGANIZATION
AND CITIZENSHIP* (OTHER THAN GAMBRO AB)
--------------------- -------------------------------------------
DIRECTORS OF GAMBRO AB
----------------------
Mikael Lilius Chairman, President and Chief Executive
Officer of Incentive AB, P.O. Box 7373,
Hamngatan 2, S-10391, Stockholm, Sweden.
Lennart Nilsson President and Chief Executive Officer of
Investment AB Cardo, Roskildevagen 1B, Box
486, S-201 24, Malmo, Sweden.
Tore Daun Director and former President, Molnlycke AB,
Molndal, Sweden, Kobbehallsv 10, S-43600,
Askim, Sweden.
Margareta Nilsson Vice Chairman, Katedervagen 5, S-224 67 Lund,
Sweden.
Berthold Lindqvist President and Chief Executive Officer of
Gambro AB.
Anitha Svensson-Grane Employee representative of Gambro AB.
Gosta Gahrton Professor, Chief of Department of Medicine,
Huddinge Hospital, Stockholm, Sweden,
Hallingsbacken 8, S-161 28 Bromma.
Karl Olof Tell Employee representative of Gambro AB.
Soren Mellstig Senior Vice President of Incentive AB.
Claes Wilhelmsson Board Member.
--------------------
* Unless otherwise indicated, the business address of each of the named
persons is P.O. Box 10101, Magistratsvagen 16, S-220 10 Lund, Sweden.
Each person listed above, unless otherwise indicated, is a citizen of
Sweden.
15
<PAGE>
DIRECTORS AND EXECUTIVE OFFICERS OF GAMBRO AB
---------------------------------------------
PRESENT PRINCIPAL OCCUPATION OR EMPLOYMENT,
INCLUDING NAME, PRINCIPAL BUSINESS AND
NAME, BUSINESS ADDRESS ADDRESS OF SUCH CORPORATION OR ORGANIZATION
AND CITIZENSHIP* (OTHER THAN GAMBRO AB)
---------------------- -------------------------------------------
EXECUTIVE MANAGEMENT OF GAMBRO AB
---------------------------------
Berthold Lindqvist President and Chief Executive Officer of
Gambro AB.
Lawrence J. Centella(USA) President and Chief Executive Officer of REN
Corporation-USA, 1820 Charlotte Pike,
Nashville, TN
Edward J. Giachetti(USA) Vice President of COBE Laboratories, Inc. and
President of COBE Cardiovascular, Inc.,
1185 Oak Street, Lakewood, CO 80215
Jan Gustavsson Chief Financial Officer of Gambro AB.
Ugo Grondelli (Italy) Senior Executive Vice President and Deputy
Managing Director of Gambro AB, Via Aldo Moro
1/A, I-43035, Felino (PR), Italy
Leif Smeby Research Director of Gambro AB.
Alain Granger (France) President of Hospal AG, Hogamed S.A. and
Hospal International Marketing, 188 Av.
Jean-Jaures, F-69007, Lyon, France.
Mats Wahlstrom Director and President of COBE Laboratories,
Inc., 1185 Oak Street, Lakewood CO 80215
Executive Vice President of Gambro AB;
Director, Chairman of the Board, President,
Assistant Secretary and Assistant Treasurer
of REN Acquisition Corp., 1185 Oak Street,
Lakewood, CO 80215
Jan-Olof Olsson President of Gambro Lundia AB and Gambro
Dialysatoren GmbH & Co. KG.
Edward C. Wood, Jr.(USA) President of COBE BCT, Inc., 1201 Oak Street,
Lakewood, CO 80215-4498.
--------------------
* Unless otherwise indicated, the business address of each of the named
persons is P.O. Box 10101, Magistratsvagen 16, S-220 10 Lund, Sweden.
Each person listed above, unless otherwise indicated, is a citizen of
Sweden.
16
<PAGE>
SCHEDULE III
DIRECTORS AND EXECUTIVE OFFICERS OF INCENTIVE AB
------------------------------------------------
PRESENT PRINCIPAL OCCUPATION OR EMPLOYMENT,
INCLUDING NAME, PRINCIPAL BUSINESS AND
NAME, BUSINESS ADDRESS ADDRESS OF SUCH CORPORATION OR ORGANIZATION
AND CITIZENSHIP* (OTHER THAN INCENTIVE AB)
--------------------------- ---------------------------------------------
DIRECTORS OF INCENTIVE AB
-------------------------
Anders Scharp Chairman of Incentive AB. Chairman of the
Boards of Electrolux, Saab-Scania and SKF;
Vice Chairman of the Boards of Investor and
Atlas Copco; Member of the Boards of Email
Ltd. (Australia), the Swedish Employers'
Confederation, the Federation of Swedish
Mechanical Engineering Industries and the
Federation of Swedish Industries.
Claes Dahlback President of Investor; Chairman of the Board
of Vin & Sprit AB; Vice Chairman of the
Board of ASEA; Member of the Boards of ABB,
Astra, Electrolux, Ericsson, Saab-Scania, SKF
and STORA.
Casimir Ehrnrooth Chairman of the Boards of Kymmene Oy and
Nokia Oy.
Lennart Hagelin Chairman of the Boards of Svenska Dagblader,
Grand Hotel Holdings and Stancia; Member of
the Boards of Skandia, Axel Johnson, the
National Swedish Road Administration and
Uppsala University.
--------------------
* Unless otherwise indicated, the business address of each of the named
persons is Hamngatan 2, P.O. Box 7373, 10391, Stockholm, Sweden. Each
person listed above, unless otherwise indicated, is a citizen of Sweden.
17
<PAGE>
DIRECTORS AND EXECUTIVE OFFICERS OF INCENTIVE AB
------------------------------------------------
PRESENT PRINCIPAL OCCUPATION OR EMPLOYMENT,
INCLUDING NAME, PRINCIPAL BUSINESS AND
NAME, BUSINESS ADDRESS ADDRESS OF SUCH CORPORATION OR ORGANIZATION
AND CITIZENSHIP* (OTHER THAN INCENTIVE AB)
--------------------------- ---------------------------------------------
DIRECTORS OF INCENTIVE AB (CONTINUED)
-------------------------------------
Leif Johansson President and CEO of Electrolux.
Mikael Lilius President and CEO of Incentive AB; Chairman
of the Boards of Garphyttan Industrier and
Orrefors Kosta Boda; Member of the Boards of
Cardo, Gambro and Huhtamaki Oy.
Sven Soderberg Chairman of the Boards of Skandia and Ratos;
Member of the Boards of ASEA and STORA;
Consul General of Norway in Stockholm.
Marcus Wallenberg Executive Vice President of Investor; Vice
Chairman of the Boards of Astra and Saab-
Scania; Member of the Boards of Investor,
Saab Automobile and the Knut & Alice
Wallenberg Foundation; Deputy Member of the
Boards of SILA, ABA and SKF.
Tore Burstrom Employee representative of Incentive AB.
Ake Jacobsson Employee representative of Incentive AB;
Member of the Board of the Electricians'
Local Union.
Bengt-Ola Nygren Employee representative of Incentive AB.
Hakan Lindh Employee representative of Incentive AB.
Jan Marklund Employee representative of Incentive AB.
Dan Nilsson Employee representative of Incentive AB.
Chairman of the Local Chapter of the Swedish
Industrial Salaried Employees' Association.
--------------------
* Unless otherwise indicated, the business address of each of the named
persons is Hamngatan 2, P.O. Box 7373, 10391, Stockholm, Sweden. Each
person listed above, unless otherwise indicated, is a citizen of Sweden.
18
<PAGE>
DIRECTORS AND EXECUTIVE OFFICERS OF INCENTIVE AB
------------------------------------------------
PRESENT PRINCIPAL OCCUPATION OR EMPLOYMENT,
INCLUDING NAME, PRINCIPAL BUSINESS AND
NAME, BUSINESS ADDRESS ADDRESS OF SUCH CORPORATION OR ORGANIZATION
AND CITIZENSHIP* (OTHER THAN INCENTIVE AB)
--------------------------- ----------------------------------------------
EXECUTIVE MANAGEMENT OF INCENTIVE AB
------------------------------------
Mikael Lilius President and Chief Executive Officer
Anders Fraggstedt Executive Vice President
Anders Jagraeus Executive Vice President
Lars Fahlen Senior Vice President, Personnel
Sverker Lundkvist Senior Vice President, Finance
Soren Mellstig Senior Vice President, Corporate Control
Bengt Modeer Senior Vice President, Corporate
Communications
Kjell Spangberg Senior Vice President, Business Development,
Mergers and Acquisitions
--------------------
* Unless otherwise indicated, the business address of each of the named
persons is Hamngatan 2, P.O. Box 7373, 10391, Stockholm, Sweden. Each
person listed above, unless otherwise indicated, is a citizen of Sweden.
19
<PAGE>
SCHEDULE IV
DIRECTORS AND EXECUTIVE OFFICERS OF REN ACQUISITION CORP.
---------------------------------------------------------
PRESENT PRINCIPAL OCCUPATION OR EMPLOYMENT,
INCLUDING NAME, PRINCIPAL BUSINESS AND
NAME, BUSINESS ADDRESS ADDRESS OF SUCH CORPORATION OR ORGANIZATION
AND CITIZENSHIP* (OTHER THAN REN ACQUISITION CORP.)
--------------------------- ----------------------------------------------
DIRECTORS OF REN ACQUISITION CORP.
----------------------------------
Mats Wahlstrom (Sweden) Director and President of COBE Laboratories,
Inc.; Executive Vice President of Gambro AB.
Herbert S. Lawson Vice President, Chief Financial Officer,
Treasurer and Assistant Secretary of COBE
Laboratories, Inc.
Ralph Z. Levy, Jr. Executive Vice President, Secretary and
General Counsel of REN Corporation-USA.
--------------------
* Unless otherwise indicated, the business address of each of the named
persons is 1185 Oak Street, Lakewood, Colorado 80215. Each person
listed above, unless otherwise indicated, is a citizen of the U.S.A.
20
<PAGE>
DIRECTORS AND EXECUTIVE OFFICERS OF REN ACQUISITION CORP.
---------------------------------------------------------
PRESENT PRINCIPAL OCCUPATION OR EMPLOYMENT,
INCLUDING NAME, PRINCIPAL BUSINESS AND
NAME, BUSINESS ADDRESS ADDRESS OF SUCH CORPORATION OR ORGANIZATION
AND CITIZENSHIP* (OTHER THAN REN ACQUISITION CORP.)
--------------------------- ----------------------------------------------
EXECUTIVE MANAGEMENT OF REN ACQUISITION CORP.
---------------------------------------------
Mats Wahlstrom (Sweden) Director and President of COBE Laboratories,
Inc.; Executive Vice President of Gambro AB.
Herbert S. Lawson Vice President, Chief Financial Officer,
Treasurer and Assistant Secretary of COBE
Laboratories, Inc.
Ralph Z. Levy, Jr. Executive Vice President, Secretary and
General Counsel of REN Corporation-USA.
--------------------
* Unless otherwise indicated, the business address of each of the named
persons is 1185 Oak Street, Lakewood, Colorado 80215. Each person
listed above, unless otherwise indicated, is a citizen of the U.S.A.
21
<PAGE>
EXHIBIT INDEX
-------------
EXHIBIT DESCRIPTION
------- -----------
R Offer Request Letter, dated as of September
12, 1995, from the Board of the Issuer
addressed to the Purchaser.
S Agreement and Plan of Merger, dated as of
September 12, 1995 (the "Merger Agreement"),
------------------
among the Issuer and Gambro, the Purchaser and
REN Acquisition Corp.
T Press Release issued by the Issuer on
September 13, 1995.
EXHIBIT R
[REN Corporation-USA Letterhead]
September 12, 1995
COBE Laboratories, Inc.
1185 Oak Street
Lakewood, Colorado 80215
Attention: Mats Wahlstrom
Re: Request for Proposal to Acquire Common Stock
--------------------------------------------
Gentlemen:
As of the date hereof and pursuant to Section 5.11 of the Stock
Purchase Agreement dated as of May 24, 1991 between REN Corporation-USA
(the "Corporation") and COBE Laboratories, Inc. ("COBE"), as amended
through April 26, 1994, the Corporation, pursuant to the duly authorized
action of its Board of Directors, hereby requests Gambro AB, a Swedish
company ("Gambro"), COBE, a wholly owned indirect subsidiary of Gambro, and
REN Acquisition Corp., a Tennessee corporation and a wholly owned
subsidiary of COBE ("Purchaser"), to enter into an Agreement and Plan of
Merger, dated as of September 12, 1995, among Gambro, COBE, Purchaser and
the Corporation and to consummate the transactions contemplated thereby in
accordance with the terms and conditions thereof.
Very truly yours,
REN Corporation-USA
By: ____________________
Name:
Title:
EXHIBIT S
===========================================================================
AGREEMENT AND PLAN OF MERGER
Among
GAMBRO AB,
COBE LABORATORIES, INC.,
REN ACQUISITION CORP.
and
REN CORPORATION-USA
Dated as of September 12, 1995
===========================================================================
<PAGE>
Glossary of Defined Terms
[(Not Part of this Agreement)]
----------------------------
Defined Term Location of Definition
------------ ----------------------
affiliate . . . . . . . . . . . . . . . . Sec. 8.04(a)
Agreement . . . . . . . . . . . . . . . . Preamble
Alex. Brown . . . . . . . . . . . . . . . Recitals
Articles of Merger . . . . . . . . . . . . Sec. 2.02
beneficial owner . . . . . . . . . . . . . Sec. 8.04(b)
Blue Sky Laws . . . . . . . . . . . . . . Sec. 3.04(b)
Board . . . . . . . . . . . . . . . . . . Recitals
business day . . . . . . . . . . . . . . . Sec. 8.04(c)
Certificates . . . . . . . . . . . . . . . Sec. 2.08(b)
Company . . . . . . . . . . . . . . . . . Preamble
Company Common Stock . . . . . . . . . . . Recitals
Company Preferred Stock . . . . . . . . . Sec. 3.02
control . . . . . . . . . . . . . . . . . Sec. 8.04(d)
Disclosure Schedule . . . . . . . . . . . Sec. 3.01
Dissenting Shares . . . . . . . . . . . . Sec. 2.07(a)
Effective Time . . . . . . . . . . . . . . Sec. 2.02
ESPP . . . . . . . . . . . . . . . . . . . Sec. 2.11
Exchange Act . . . . . . . . . . . . . . . Sec. 1.02(b)
Gambro . . . . . . . . . . . . . . . . . . Preamble
Indemnified Parties . . . . . . . . . . . Sec. 5.03(c)
Material Adverse Effect . . . . . . . . . Sec. 3.01
Merger . . . . . . . . . . . . . . . . . . Recitals
Merger Consideration . . . . . . . . . . . Sec. 2.06(a)
Offer . . . . . . . . . . . . . . . . . . Recitals
Offer Documents . . . . . . . . . . . . . Sec. 1.01(b)
Offer to Purchase . . . . . . . . . . . . Sec. 1.01(b)
Option . . . . . . . . . . . . . . . . . . Sec. 2.09
Parent . . . . . . . . . . . . . . . . . . Preamble
Paying Agent . . . . . . . . . . . . . . . Sec. 2.08(a)
Per Share Amount . . . . . . . . . . . . . Recitals
person . . . . . . . . . . . . . . . . . . Sec. 8.03(e)
Plan Amount . . . . . . . . . . . . . . . Sec. 2.11
Proxy Statement . . . . . . . . . . . . . Sec. 3.07
Purchaser . . . . . . . . . . . . . . . . Preamble
Schedule 14D-9 . . . . . . . . . . . . . . Sec. 1.02(b)
Schedule 14D-1 . . . . . . . . . . . . . . Sec. 1.01(b)
Schedule 13E-3 . . . . . . . . . . . . . . Sec. 1.01(b)
SEC . . . . . . . . . . . . . . . . . . . Sec. 1.01(b)
SEC Reports . . . . . . . . . . . . . . . Sec. 3.06(a)
Securities Act . . . . . . . . . . . . . . Sec. 3.06(a)
Series A Preferred Stock . . . . . . . . . Sec. 3.02
Series B Preferred Stock . . . . . . . . . Sec. 3.02
Shares . . . . . . . . . . . . . . . . . . Recitals
<PAGE>
Defined Term Location of Definition
------------ ----------------------
Special Committee . . . . . . . . . . . . Recitals
Stockholders' Meeting . . . . . . . . . . Sec. 5.01
Stock Option Plan . . . . . . . . . . . . Sec. 2.09
Stock Purchase Agreement . . . . . . . . . Recitals
Subsidiary . . . . . . . . . . . . . . . . Sec. 3.01
subsidiary . . . . . . . . . . . . . . . . Sec. 8.04(f)
Surviving Corporation . . . . . . . . . . Sec. 2.01
Tennessee Law . . . . . . . . . . . . . . Recitals
Termination Date . . . . . . . . . . . . . Sec. 2.11
Transactions . . . . . . . . . . . . . . . Sec. 3.03
Warrant . . . . . . . . . . . . . . . . . Sec. 2.10
<PAGE>
TABLE OF CONTENTS
PAGE
SECTION 1.02. Company Action . . . . . . . . . . . . . . . . . . 3
ARTICLE II
THE MERGER
SECTION 2.01. The Merger . . . . . . . . . . . . . . . . . . . . 4
SECTION 2.02. Effective Time; Closing . . . . . . . . . . . . . . 5
SECTION 2.03. Effect of the Merger . . . . . . . . . . . . . . . 5
SECTION 2.04. Charter; By-laws . . . . . . . . . . . . . . . . . 5
SECTION 2.05. Directors and Officers . . . . . . . . . . . . . . 5
SECTION 2.06. Conversion of Securities . . . . . . . . . . . . . 5
SECTION 2.07. Dissenting Shares . . . . . . . . . . . . . . . . . 6
SECTION 2.08. Surrender of Shares; Stock Transfer Books . . . . . 7
SECTION 2.09. Employee Stock Options. . . . . . . . . . . . . . . 8
SECTION 2.10. Warrants . . . . . . . . . . . . . . . . . . . . . 8
SECTION 2.11. Employee Stock Purchase Plan . . . . . . . . . . . 9
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
SECTION 3.01. Organization and Qualification; Subsidiaries . . . 9
SECTION 3.02. Capitalization . . . . . . . . . . . . . . . . . . 10
SECTION 3.03. Authority Relative to this Agreement . . . . . . . 11
SECTION 3.04. No Conflict; Required Filings and Consents . . . . 11
SECTION 3.05. Compliance . . . . . . . . . . . . . . . . . . . . 12
SECTION 3.06. SEC Filings; Financial Statements . . . . . . . . . 12
SECTION 3.07. Offer Documents; Schedule 14D-9; Schedule 13E-3;
Proxy Statement . . . . . . . . . . . . . . . . . 13
SECTION 3.08. Brokers . . . . . . . . . . . . . . . . . . . . . . 14
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF GAMBRO, PARENT AND PURCHASER
SECTION 4.01. Corporate Organization . . . . . . . . . . . . . . 14
SECTION 4.02. Authority Relative to this Agreement . . . . . . . 14
SECTION 4.03. No Conflict; Required Filings and Consents . . . . 15
SECTION 4.04. Financing . . . . . . . . . . . . . . . . . . . . . 15
SECTION 4.05. Offer Documents; Proxy Statement . . . . . . . . . 15
SECTION 4.06. Full Disclosure . . . . . . . . . . . . . . . . . . 16
SECTION 4.07. Brokers . . . . . . . . . . . . . . . . . . . . . . 16
ARTICLE V
<PAGE>
PAGE
ADDITIONAL AGREEMENTS
SECTION 5.01. Stockholders' Meeting . . . . . . . . . . . . . . . 16
SECTION 5.02. Proxy Statement . . . . . . . . . . . . . . . . . . 17
SECTION 5.03. Directors' and Officers' Indemnification and
Insurance . . . . . . . . . . . . . . . . . . . . 17
SECTION 5.04. Further Action; Reasonable Best Efforts . . . . . . 19
SECTION 5.05. Public Announcements . . . . . . . . . . . . . . . 19
SECTION 5.06. Gambro Guarantee . . . . . . . . . . . . . . . . . 19
ARTICLE VI
CONDITIONS TO THE MERGER
SECTION 6.01. Conditions to the Merger . . . . . . . . . . . . . 19
ARTICLE VII
TERMINATION, AMENDMENT AND WAIVER
SECTION 7.01. Termination . . . . . . . . . . . . . . . . . . . . 20
SECTION 7.02. Effect of Termination . . . . . . . . . . . . . . . 22
SECTION 7.03. Fees and Expenses . . . . . . . . . . . . . . . . . 22
SECTION 7.04. Amendment . . . . . . . . . . . . . . . . . . . . . 22
SECTION 7.05. Waiver . . . . . . . . . . . . . . . . . . . . . . 22
ARTICLE VIII
GENERAL PROVISIONS
SECTION 8.01. Non-Survival of Representations, Warranties and
Agreements . . . . . . . . . . . . . . . . . . . 22
SECTION 8.02. Notices . . . . . . . . . . . . . . . . . . . . . . 23
SECTION 8.03. Enforcement of Agreement . . . . . . . . . . . . . 24
SECTION 8.04. Certain Definitions . . . . . . . . . . . . . . . . 24
SECTION 8.05. Severability . . . . . . . . . . . . . . . . . . . 25
SECTION 8.06. Entire Agreement; Assignment . . . . . . . . . . . 26
SECTION 8.07. Parties in Interest . . . . . . . . . . . . . . . . 26
SECTION 8.08. Specific Performance . . . . . . . . . . . . . . . 26
SECTION 8.09. Governing Law . . . . . . . . . . . . . . . . . . . 26
SECTION 8.10. Headings . . . . . . . . . . . . . . . . . . . . . 26
SECTION 8.11. Counterparts . . . . . . . . . . . . . . . . . . . 26
ANNEX A - Conditions to the Offer
<PAGE>
AGREEMENT AND PLAN OF MERGER dated as of September 12, 1995
(this "Agreement") among Gambro AB, a Swedish corporation ("Gambro"), COBE
--------- ------
Laboratories, Inc., a Colorado corporation and an indirect wholly owned
subsidiary of Gambro ("Parent"), REN Acquisition Corp., a Tennessee
------
corporation and a wholly owned subsidiary of Parent ("Purchaser"), and REN
---------
Corporation-USA, a Tennessee corporation (the "Company").
-------
WHEREAS, on September 12, 1995, Parent contributed to the capital
of Purchaser 10,036,221 shares of issued and outstanding Common Stock, no
par value, of the Company ("Company Common Stock") (outstanding shares of
--------------------
Company Common Stock being hereinafter collectively referred to as the
"Shares") representing approximately 53% of the Shares; and
------
WHEREAS, the Boards of Directors of Gambro, Parent and Purchaser
and the Board of Directors of the Company (the "Board"), acting upon the
-----
unanimous recommendation of the Special Committee of independent directors
of the Board (the "Special Committee"), have each determined that it is in
-----------------
the best interests of their respective stockholders for Parent to acquire
the Company upon the terms and subject to the conditions set forth herein;
and
WHEREAS, in furtherance of such acquisition, it is proposed that
Purchaser shall make a cash tender offer (the "Offer") to acquire all the
-----
issued and outstanding Shares for $20.00 per Share (such amount, or any
greater amount per Share paid pursuant to the Offer, being hereinafter
referred to as the "Per Share Amount"), net to the seller in cash, upon the
----------------
terms and subject to the conditions of this Agreement and the Offer; and
WHEREAS, the Board, acting upon the unanimous recommendation of
the Special Committee, has unanimously (A) determined that this Agreement
and the transactions contemplated hereby are fair to and in the best
interests of the stockholders of the Company, (B) approved and adopted this
Agreement and the transactions contemplated hereby, including the making of
the Offer and resolved and agreed to recommend that holders of Shares
tender their Shares pursuant to the Offer, and (C) pursuant to Section 5.11
of the Stock Purchase Agreement dated as of May 24, 1991, as amended
through April 26, 1994, between Parent and the Company (the "Stock Purchase
--------------
Agreement"), the Board has requested that Gambro, Parent and Purchaser
---------
enter into this Agreement and consummate the transactions contemplated
hereby in accordance with the terms and conditions of this Agreement; and
WHEREAS, also in furtherance of such acquisition, the Board,
acting upon the unanimous recommendation of the Special Committee, and the
Boards of Directors of Parent and Purchaser have each approved the merger
(the "Merger") of Purchaser with and into the Company in accordance with
------
the Tennessee Business Corporation Act ("Tennessee Law") following the
-------------
consummation of the Offer and upon the terms and subject to the conditions
set forth herein; and
WHEREAS, the Company has been advised by each of its directors
and executive officers that they intend either to tender all Shares
beneficially owned by them to Purchaser pursuant to the Offer or to vote
all Shares beneficially owned by them in favor of the approval and adoption
by the stockholders of the Company of this Agreement and the transactions
contemplated hereby; and
WHEREAS, Alex. Brown & Sons Incorporated ("Alex. Brown") has
-----------
delivered to the Special Committee an opinion (the "Fairness Opinion") that
------------------
the consideration to be received by the holders of Shares, other than
Gambro, Purchaser, Parent or any of their affiliates, pursuant to this
Agreement is fair to the holders of such Shares from a financial point of
view;
<PAGE>
2
NOW, THEREFORE, in consideration of the foregoing and the mutual
covenants and agreements herein contained, and intending to be legally
bound hereby, Gambro, Parent, Purchaser and the Company hereby agree as
follows:
ARTICLE I
THE OFFER
---------
SECTION 1.01. The Offer. (a) Provided that this Agreement
---------
shall not have been terminated in accordance with Section 7.01 and none of
the events set forth in Annex A hereto shall have occurred or be existing,
Purchaser shall commence the Offer as promptly as reasonably practicable
after the date hereof, but in no event later than five business days after
the initial public announcement of Purchaser's intention to commence the
Offer. The obligation of Purchaser to accept for payment and pay for
Shares tendered pursuant to the Offer shall be subject to the condition
(the "Minimum Condition") that at least a majority of the then outstanding
-----------------
Shares, other than Shares owned beneficially by or of record by Gambro,
Parent, Purchaser or any of their affiliates, shall have been validly
tendered and not withdrawn prior to the expiration of the Offer and also
shall be subject to the satisfaction of the other conditions set forth in
Annex A hereto. Purchaser expressly reserves the right to waive any such
condition, to increase the price per Share payable in the Offer, and to
make any other changes in the terms and conditions of the Offer; provided,
--------
however, that the Minimum Condition may not be waived except with the prior
-------
written consent of the Special Committee; and provided further that no
-------- -------
change may be made which decreases the price per Share payable in the Offer
or which reduces the maximum number of Shares to be purchased in the Offer
or which imposes conditions to the Offer in addition to those set forth in
Annex A hereto. The Per Share Amount shall, subject to applicable
withholding of taxes, be net to the seller in cash, upon the terms and
subject to the conditions of the Offer. Subject to the terms and
conditions of the Offer, Purchaser shall pay, as promptly as practicable
after expiration of the Offer, for all Shares validly tendered and not
withdrawn.
(b) As promptly as reasonably practicable on the date of
commencement of the Offer, Purchaser shall file with the Securities and
Exchange Commission (the "SEC") (i) a Tender Offer Statement on
---
Schedule 14D-1 (together with all amendments and supplements thereto, the
"Schedule 14D-1") with respect to the Offer and (ii) a Rule 13e-3
--------------
Transaction Statement on Schedule 13E-3 (together with all amendments and
supplements thereto, the "Schedule 13E-3") with respect to the Offer and
--------------
the other Transactions (as hereinafter defined). The Schedule 14D-1 and
the Schedule 13E-3 shall contain or shall incorporate by reference an offer
to purchase (the "Offer to Purchase") and forms of the related letter of
-----------------
transmittal and any related summary advertisement (the Schedule 14D-1, the
Schedule 13E-3, the Offer to Purchase and such other documents, together
with all supplements and amendments thereto, being referred to herein
collectively as the "Offer Documents"). Gambro, Parent, Purchaser and the
---------------
Company agree to correct promptly any information provided by any of them
for use in the Offer Documents which shall have become false or misleading,
and Gambro, Parent and Purchaser further agree to take all steps necessary
to cause the Schedule 14D-1 and the Schedule 13E-3 as so corrected to be
filed with the SEC and the other Offer Documents as so corrected to be
disseminated to holders of Shares, in each case as and to the extent
required by applicable federal securities laws.
SECTION 1.02. Company Action. (a) The Company, acting through
--------------
the Board
<PAGE>
3
acting upon the unanimous recommendation of the Special Committee, hereby
approves of and consents to the Offer and represents that (i) the Board,
acting upon the unanimous recommendation of the Special Committee, at a
meeting duly called and held on September 12, 1995, has unanimously
(A) determined that this Agreement and the transactions contemplated
hereby, including each of the Offer and the Merger, are fair to and in the
best interests of the holders of Shares, (B) approved and adopted this
Agreement, the execution of this Agreement and the transactions
contemplated by this Agreement, which approval includes the approval of a
majority of the Company's disinterested directors, and (C) recommended that
the stockholders of the Company accept the Offer and approve and adopt this
Agreement and the transactions contemplated hereby, and (ii) Alex. Brown
has delivered to the Special Committee an opinion that the consideration to
be received by the holders of Shares, other than Gambro, Purchaser, Parent
or any of their affiliates, pursuant to this Agreement is fair to the
holders of such Shares from a financial point of view. Subject to the
fiduciary duties of the Board under applicable law as advised by outside
counsel, the Company hereby consents to the inclusion in the Offer
Documents of the unanimous recommendation of the Board, acting upon the
unanimous recommendation of the Special Committee, described in the
immediately preceding sentence. The Company has been advised by each of
its directors and executive officers that they intend either to tender all
Shares beneficially owned by them to Purchaser pursuant to the Offer or to
vote such Shares in favor of the approval and adoption by the stockholders
of the Company of this Agreement and the transactions contemplated hereby.
(b) As promptly as reasonably practicable on the date of
commencement of the Offer, the Company shall file with the SEC a
Solicitation/Recommendation Statement on Schedule 14D-9 (together with all
amendments and supplements thereto, the "Schedule 14D-9") containing,
--------------
subject to the fiduciary duties of the Board under applicable law as
advised by outside counsel, the recommendation of the Board, acting upon
the unanimous recommendation of the Special Committee, described in
Section 1.02(a) and shall disseminate the Schedule 14D-9 to the extent
required by Rule 14d-9 promulgated under the Securities Exchange Act of
1934, as amended (the "Exchange Act"), and any other applicable federal
------------
securities laws. The Company, Gambro, Parent and Purchaser agree to
correct promptly any information provided by any of them for use in the
Schedule 14D-9 which shall have become false or misleading, and the Company
further agrees to take all steps necessary to cause the Schedule 14D-9 as
so corrected to be filed with the SEC and disseminated to holders of
Shares, in each case as and to the extent required by applicable federal
securities laws.
(c) The Company shall promptly furnish Purchaser with mailing
labels containing the names and addresses of all record holders of Shares
and with security position listings of Shares held in stock depositories,
each as of a recent date, together with all other available listings and
computer files containing names, addresses and security position listings
of record holders and beneficial owners of Shares. The Company shall
furnish Purchaser with such additional information, including, without
limitation, updated listings and computer files of stockholders, mailing
labels and security position listings, and such other assistance as Parent,
Purchaser or their agents may reasonably request. Subject to the
requirements of applicable law, and except for such steps as are necessary
to disseminate the Offer Documents and any other documents necessary to
consummate the Offer or the Merger, Gambro, Parent and Purchaser shall hold
in confidence the information contained in such labels, listings and files,
shall use such information only in connection with the Offer and the
Merger, and, if this Agreement shall be terminated in accordance with
Section 7.01, shall deliver to the Company all copies of such information
then in their possession.
<PAGE>
4
(d) For purposes of this Agreement, the fiduciary duties of the
Board or the Company under applicable law as advised by outside counsel
shall be determined by the Special Committee.
ARTICLE II
THE MERGER
----------
SECTION 2.01. The Merger. Upon the terms and subject to the
----------
conditions set forth in Article VI, and in accordance with Tennessee Law,
at the Effective Time (as hereinafter defined) Purchaser shall be merged
with and into the Company. As a result of the Merger, the separate
corporate existence of Purchaser shall cease and the Company shall continue
as the surviving corporation after the Merger (the "Surviving Corporation").
---------------------
SECTION 2.02. Effective Time; Closing. As promptly as
-----------------------
practicable after the satisfaction or, if permissible, waiver of the
conditions set forth in Article VI, the parties hereto shall cause the
Merger to be consummated by filing Articles of Merger with the Secretary of
State of the State of Tennessee (the "Articles of Merger"), in such form as
------------------
is required by, and executed in accordance with the relevant provisions of,
Tennessee Law (the date and time of such filing being the "Effective
---------
Time"). Prior to such filing, a closing shall be held at the offices of
----
Shearman & Sterling, 599 Lexington Avenue, New York, New York, 10022, or
such other place as the parties shall agree, for the purpose of confirming
the satisfaction or waiver, as the case may be, of the conditions set forth
in Article VI.
SECTION 2.03. Effect of the Merger. At the Effective Time, the
--------------------
effect of the Merger shall be as provided in the applicable provisions of
Tennessee Law. Without limiting the generality of the foregoing, and
subject thereto, at the Effective Time all the property, rights,
privileges, powers and franchises of the Company and Purchaser shall vest
in the Surviving Corporation, and all debts, liabilities, obligations,
restrictions, disabilities and duties of the Company and Purchaser shall
become the debts, liabilities, obligations, restrictions, disabilities and
duties of the Surviving Corporation.
SECTION 2.04. Charter; By-laws. (a) Subject to Section 5.03,
----------------
at the Effective Time the Charter of the Company, as in effect immediately
prior to the Effective Time, shall be the Charter of the Surviving
Corporation until thereafter amended as provided by law and such Charter.
(b) Subject to Section 5.03, at the Effective Time the By-laws
of the Company, as in effect immediately prior to the Effective Time, shall
be the By-laws of the Surviving Corporation until thereafter amended as
provided by law, the Charter of the Surviving Corporation and such By-laws.
SECTION 2.05. Directors and Officers. The directors of the
----------------------
Company immediately prior to the Effective Time shall be the directors of
the Surviving Corporation immediately following the Merger, each to hold
office in accordance with the Charter and By-laws of the Surviving
Corporation, and the officers of the Company immediately prior to the
Effective Time shall be the officers of the Surviving Corporation
immediately following the Merger, in each case until their respective
successors are duly elected or appointed and qualified.
<PAGE>
5
SECTION 2.06. Conversion of Securities. At the Effective Time,
------------------------
by virtue of the Merger and without any further action on the part of
Purchaser, the Company or the holders of any of the following securities,
other than as specified herein:
(a) Each Share issued and outstanding immediately prior to
the Effective Time (other than any Shares to be cancelled pursuant to
Section 2.06(b) and any Dissenting Shares (as hereinafter defined))
shall be cancelled and shall be converted automatically into the right
to receive an amount equal to the Per Share Amount in cash (the
"Merger Consideration") payable, without interest, to the holder of
--------------------
such Share, upon surrender, in the manner provided in Section 2.08, of
the certificate that formerly evidenced such Share;
(b) Each Share held by the Company and each Share owned by
Purchaser, Parent or any direct or indirect wholly owned subsidiary of
Parent or of the Company immediately prior to the Effective Time shall
be cancelled without any conversion thereof and no payment or
distribution shall be made with respect thereto; and
(c) Each share of Common Stock, par value $.01 per share,
of Purchaser issued and outstanding immediately prior to the Effective
Time shall be converted into and exchanged for one validly issued,
fully paid and nonassessable share of Common Stock of the Surviving
Corporation.
SECTION 2.07. Dissenting Shares. (a) Notwithstanding any
-----------------
provision of this Agreement to the contrary, any Shares of a record or
beneficial owner who has properly demanded and perfected his right for
appraisal of such shares in accordance with Tennessee Law and who, as of
the Effective Time, has not effectively withdrawn or lost such right to
appraisal (collectively, the "Dissenting Shares") shall not be converted
-----------------
into or represent the right to receive the Merger Consideration. Such
stockholders shall be entitled to receive payment of the appraised value of
such Shares held by them in accordance with the provisions of Tennessee
Law, except that all Shares held by stockholders who shall have failed to
perfect or who effectively shall have withdrawn or lost their rights to
appraisal of such Shares under Tennessee Law shall thereupon be deemed to
have been converted into, and to have become exchangeable for, as of the
Effective Time, the right to receive the Merger Consideration, without any
interest thereon, upon surrender, in the manner provided in Section 2.08,
of the certificate or certificates that formerly evidenced such Shares.
(b) The Company shall give Parent (i) prompt notice of any
demands for appraisal received by the Company, withdrawals of such demands,
and any other instruments served pursuant to Tennessee Law and received by
the Company and (ii) the opportunity to direct all negotiations and
proceedings with respect to demands for appraisal under Tennessee Law. The
Company shall not, except with the prior written consent of Parent, make
any payment with respect to any demands for appraisal or offer to settle or
settle any such demands.
SECTION 2.08. Surrender of Shares; Stock Transfer Books. (a)
-----------------------------------------
Prior to the Effective Time, Purchaser shall deposit the full amount of the
Merger Consideration with Bank of New York, as agent (the "Paying Agent"),
------------
for the holders of Shares in connection with the Merger to receive the
funds to which holders of Shares shall become entitled pursuant to
Section 2.06(a). Such funds shall be invested by the Paying Agent as
directed by the Surviving Corporation.
(b) Promptly after the Effective Time, the Surviving Corporation
shall cause to be
<PAGE>
6
mailed to each person who was, at the Effective Time, a holder of record of
Shares entitled to receive the Merger Consideration pursuant to
Section 2.06(a), a form of letter of transmittal (which shall specify that
delivery shall be effected, and risk of loss and title to the certificates
evidencing such Shares (the "Certificates") shall pass, only upon proper
------------
delivery of the Certificates to the Paying Agent) and instructions for use
in effecting the surrender of the Certificates pursuant to such letter of
transmittal. Upon surrender to the Paying Agent of a Certificate, together
with such letter of transmittal, duly completed and validly executed in
accordance with the instructions thereto, and such other documents as may
be required pursuant to such instructions, the holder of such Certificate
shall be entitled to receive in exchange therefor the Merger Consideration
for each Share formerly evidenced by such Certificate, and such Certificate
shall then be cancelled. No interest shall accrue or be paid on the Merger
Consideration payable upon the surrender of any Certificate for the benefit
of the holder of such Certificate. If payment of the Merger Consideration
is to be made to a person other than the person in whose name the
surrendered Certificate is registered on the stock transfer books of the
Company, it shall be a condition of payment that the Certificate so
surrendered shall be endorsed properly or otherwise be in proper form for
transfer and that the person requesting such payment shall have paid all
transfer and other taxes required by reason of the payment of the Merger
Consideration to a person other than the registered holder of the
Certificate surrendered or shall have established to the satisfaction of
the Surviving Corporation that such taxes either have been paid or are not
applicable.
(c) At any time following the first anniversary of the Effective
Time, the Surviving Corporation shall be entitled to require the Paying
Agent to deliver to it any funds which had been made available to the
Paying Agent and not disbursed to holders of Shares (including, without
limitation, all interest and other income received by the Paying Agent in
respect of all funds made available to it), and thereafter such holders
shall be entitled to look to the Surviving Corporation (subject to
abandoned property, escheat and other similar laws) only as general
creditors thereof with respect to any Merger Consideration that may be
payable upon due surrender of the Certificates held by them.
Notwithstanding the foregoing, neither the Surviving Corporation nor the
Paying Agent shall be liable to any holder of any Share(s) for any Merger
Consideration delivered in respect of such Share(s) to a public official
pursuant to any abandoned property, escheat or other similar law.
(d) At the close of business on the day of the Effective Time,
the stock transfer books of the Company shall be closed and thereafter
there shall be no further registration of transfers of Shares on the
records of the Company. From and after the Effective Time, the holders of
Shares outstanding immediately prior to the Effective Time shall cease to
have any rights with respect to such Shares except as otherwise provided
herein or by applicable law.
SECTION 2.09. Employee Stock Options. (a) Each holder of a
----------------------
stock option (an "Option") to purchase shares of Company Common Stock under
------
the Company's Non-Statutory Stock Option Plan of 1988, as amended (the
"Stock Option Plan"), which Option is outstanding immediately prior to the
-----------------
Effective Time (whether or not then exercisable) shall, pursuant to the
Cancellation of Option Agreements entered into by the Company with each of
the Optionees (as defined in such Cancellation of Option Agreements), be
entitled to receive, and shall receive, in settlement and cancellation
thereof, an amount in cash equal to the product of (i) the excess, if any,
of the Per Share Amount over the exercise price of each such Option and
(ii) the number of shares of Company Common Stock covered by such Option.
All payments by the Company in respect of Options, other than Options
granted within six months prior to the Effective Time, shall be made
promptly following the Effective Time. Payments in respect of Options
granted within six months prior to the Effective
<PAGE>
7
Time shall be made six months and one day after the date of grant of such
Options. No person shall be entitled to receive any of the payments
described in this Section 2.09 until the time established therefor in this
Section 2.09. The Company shall cause the Stock Option Plan to terminate
as of the Effective Time and certificates evidencing Options shall be
deemed to be cancelled as of the Effective Time, and thereafter the only
rights of participants therein shall be the right to receive the
consideration set forth in this Section 2.09. Prior to the Effective Time,
the Company shall use its reasonable best efforts to cause each holder of
an outstanding Option to acknowledge in writing the cancellation of such
Option and to release the Company from any obligation in respect thereof in
consideration for the payment provided herein and shall take such other
action as may be necessary to carry out the terms of this Section 2.09.
SECTION 2.10. Warrants. (a) Each holder of a warrant (a
--------
"Warrant") to purchase shares of Company Common Stock, which Warrant is
-------
outstanding immediately prior to the Effective Time (whether or not then
exercisable) shall, pursuant to the Cancellation of Warrant Agreements
entered into by the Company with each of the Warrant Holders (as defined
in the Cancellation of Warrant Agreements), be entitled to receive, and
shall receive, in settlement and cancellation thereof, an amount in cash
equal to the product of (i) the excess, if any, of the Per Share Amount
over the exercise price of each such Warrant and (ii) the number of shares
of Company Common Stock covered by such Warrant. The Company shall cause
each such warrant agreement to which it is a party to terminate as of the
Effective Time, and thereafter the only rights of the holders of the
Warrants shall be the right to receive the consideration set forth in this
Section 2.10. Prior to the Effective Time, the Company shall use its
reasonable best efforts to cause each holder of an outstanding Warrant to
acknowledge in writing the termination of such Warrants and to release the
Company from any obligation in respect thereof in consideration for the
payment provided herein and shall take such other action as may be
necessary to carry out the terms of this Section 2.10.
SECTION 2.11. Employee Stock Purchase Plan. The Company shall
----------------------------
terminate the Company's Employee Stock Purchase Plan, as amended, of July
1, 1994 (the "ESPP"), effective September 30, 1995 (the "Termination Date")
---- ----------------
pursuant to which (i) all further payroll deductions from each Participant
(as defined in the ESPP) shall cease, (ii) the amount (the "Plan Amount")
-----------
credited to the account of each Participant as of the Termination Date
shall at the election of each Participant either (A) be paid by the Company
to such Participant (without interest) as soon as administratively
practicable or (B) be applied as of the Termination Date to the purchase of
shares of the Company's Common Stock in an aggregate amount equal to each
Participant's Plan Amount at a price per share of Common Stock equal to 85%
of the lower of the Fair Market Value (as defined in the ESPP) per share of
Common Stock on July 1, 1995 or on the Termination Date (rounded up to the
next whole dime), in accordance with the terms of the current phase under
the ESPP, and (iii) for purposes of the current phase, the Termination Date
shall be treated for all purposes of the ESPP as the last day of such
phase. In the event that a Participant makes no election under Section
2.11(ii) above, such Participant shall be deemed to have elected as of the
Termination Date to apply such Participant's Plan Amount to the purchase of
shares of the Company's Common Stock in accordance with the provisions of
Section 2.11(ii)(B) above.
<PAGE>
8
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
---------------------------------------------
The Company hereby represents and warrants to Gambro, Parent and
Purchaser that:
SECTION 3.01. Organization and Qualification; Subsidiaries.
--------------------------------------------
Each of the Company and each subsidiary of the Company (a "Subsidiary") is
----------
a corporation duly organized, validly existing and in good standing under
the laws of the jurisdiction of its incorporation and has the requisite
power and authority and all necessary governmental approvals to own, lease
and operate its properties and to carry on its business as it is now being
conducted, except where the failure to be so organized, existing or in good
standing or to have such power, authority and governmental approvals would
not, individually or in the aggregate, have a Material Adverse Effect (as
defined below). The Company and each Subsidiary is duly qualified or
licensed as a foreign corporation to do business, and is in good standing,
in each jurisdiction where the character of the properties owned, leased or
operated by it or the nature of its business makes such qualification or
licensing necessary, except for such failures to be so qualified or
licensed and in good standing that would not, individually or in the
aggregate, have a Material Adverse Effect. When used in connection with
the Company, Gambro, Parent or Purchaser or any of their Subsidiaries, the
term "Material Adverse Effect" means any change or effect that is or is
-----------------------
reasonably likely to be materially adverse to the business, operations,
properties or financial condition of the Company, Gambro, Parent or
Purchaser or any of their Subsidiaries taken as a whole. A true and
complete list of all the Subsidiaries, together with the jurisdiction of
incorporation of each Subsidiary and the percentage of the outstanding
capital stock of each Subsidiary owned by the Company and by each other
Subsidiary, is set forth in Section 3.01 of the Disclosure Schedule to this
Agreement previously delivered by the Company to Parent (the "Disclosure
----------
Schedule"). Except as disclosed in such Section 3.01, the Company does not
--------
directly or indirectly own any equity or similar interest in, or any
interest convertible into or exchangeable or exercisable for, any equity or
similar interest in, any corporation, partnership, joint venture or other
business association or entity.
SECTION 3.02. Capitalization. The authorized capital stock of
--------------
the Company consists of 60,000,000 shares of Company Common Stock and
10,000,000 shares of Preferred Stock ("Company Preferred Stock"), including
-----------------------
1,218,000 shares of Series A Preferred Stock, no par value (the "Series A
--------
Preferred Stock") and 500,000 Shares of Series B Preferred Stock, no par
---------------
value (the "Series B Preferred Stock"). As of the date hereof,
------------------------
(i) 18,951,834 shares of Company Common Stock are issued and outstanding,
all of which are validly issued, fully paid and nonassessable, (ii) 20,038
shares of Company Common Stock are held by the Company, (iii) 1,750,000
shares of Company Common Stock are reserved for issuance pursuant to
Options granted under the Stock Option Plan, and, as of the date hereof,
542,850 Options have been granted under the Stock Option Plan, (iv) 400,000
shares of Company Common Stock are reserved for issuance pursuant to
Options granted under the Company's ESPP as disclosed in Section 3.02 of
the Disclosure Schedule and (v) Warrants to purchase 74,000 shares of
Company Common Stock are outstanding. As of the date hereof, no shares of
Company Preferred Stock have been issued or are outstanding, 1,218,000
shares of Series A Preferred Stock have been issued (all of which have been
converted into shares of Company Common Stock) and 462,172 shares of Series
B Preferred Stock have been issued (all of which have been converted into
shares of Company Common Stock). Except as set forth in this Section 3.02
or in Section 3.02 of the Disclosure Schedule, there are no options,
warrants or other rights, agreements,
<PAGE>
9
arrangements or commitments of any character relating to the issued or
unissued capital stock of the Company or any Subsidiary or obligating the
Company or any Subsidiary to issue or sell any shares of capital stock of,
or other equity interests in, the Company or any Subsidiary. All Shares
subject to issuance as aforesaid, upon issuance on the terms and conditions
specified in the instruments pursuant to which they are issuable, will be
duly authorized, validly issued, fully paid and nonassessable. Except as
set forth in this Section 3.02 or in 3.02 of the Disclosure Schedule, there
are no outstanding contractual obligations of the Company or any Subsidiary
to repurchase, redeem or otherwise acquire any Shares or any capital stock
of any Subsidiary. Each outstanding share of capital stock of each
Subsidiary is duly authorized, validly issued, fully paid and nonassessable
and each such share owned by the Company or another Subsidiary is free and
clear of all security interests, liens, claims, pledges, options, rights of
first refusal, agreements, limitations on the Company's or such other
Subsidiary's voting rights, charges and other encumbrances of any nature
whatsoever.
SECTION 3.03. Authority Relative to this Agreement. The Company
------------------------------------
has all necessary power and authority to execute and deliver this Agreement
and to perform its obligations hereunder and to consummate the transactions
contemplated hereby (the "Transactions"). The execution and delivery of
------------
this Agreement by the Company and the consummation by the Company of the
Transactions have been duly and validly authorized by all necessary
corporate action, and no other corporate proceedings on the part of the
Company are necessary to authorize this Agreement or to consummate the
Transactions (other than, with respect to the Merger, the approval and
adoption of this Agreement by the holders of a majority of the then
outstanding Shares if and to the extent required by applicable law, and the
filing and recordation of appropriate merger documents as required by
Tennessee Law). This Agreement has been duly and validly executed and
delivered by the Company and, assuming the due authorization, execution and
delivery by Gambro, Parent and Purchaser, constitutes a legal, valid and
binding obligation of the Company enforceable against the Company in
accordance with its terms. The restrictions on business combinations
contained in the Tennessee Business Combination Act have been satisfied
with respect to the Transactions, the provisions of the Tennessee Investor
Protection Act do not apply to the Transactions, and the restrictions on
voting rights contained in the Tennessee Control Share Acquisition Act have
been satisfied with respect to the Transactions.
SECTION 3.04. No Conflict; Required Filings and Consents.
------------------------------------------
(a) The execution and delivery of this Agreement by the Company do not,
and the performance of this Agreement by the Company will not, (i) conflict
with or violate the Charter or By-laws or equivalent organizational
documents of the Company or any Subsidiary, (ii) conflict with or violate
any law, rule, regulation, order, judgment or decree applicable to the
Company or any Subsidiary or by which any material property or asset of the
Company or any Subsidiary is bound or affected, or (iii) result in any
breach of or constitute a default (or an event which with notice or lapse
of time or both would become a default) under, or give to others any right
of termination, amendment, acceleration or cancellation of, or result in
the creation of a lien or other encumbrance on any property or asset of the
Company or any Subsidiary pursuant to, any note, bond, mortgage, indenture,
contract, agreement, lease, license, permit, franchise or other instrument
or obligation to which the Company or any Subsidiary is a party or by which
the Company or any Subsidiary or any of their respective properties is
bound or affected, except, in the case of clauses (ii) and (iii) of this
Section 3.04, for conflicts, violations, breaches, defaults, rights, liens,
and encumbrances which would not individually or in the aggregate have a
Material Adverse Effect.
(b) The execution and delivery of this Agreement by the Company
do not, and the
<PAGE>
10
performance of this Agreement by the Company will not, require any consent,
approval, authorization or permit of, or filing with or notification to,
any governmental or regulatory authority, domestic or foreign, except
(i) for applicable requirements, if any, of the Exchange Act, the Health
Care Financing Administration, state securities or "blue sky" laws ("Blue
----
Sky Laws") and state takeover laws, and filing and recordation of
--------
appropriate merger documents as required by Tennessee Law and (ii) where
failure to obtain such consents, approvals, authorizations or permits, or
to make such filings or notifications, would not prevent or delay
consummation of the Offer or the Merger, or otherwise prevent the Company
from performing its obligations under this Agreement, and would not,
individually or in the aggregate, have a Material Adverse Effect.
(c) The approval and adoption by the Board, acting upon the
unanimous recommendation of the Special Committee, of this Agreement and
the Transactions (which approval by the Board includes the approval of a
majority of the Company's disinterested directors as set forth in Section
1.02(a)(B) of this Agreement) constitutes sufficient approval by a majority
of the Company's disinterested directors for purposes of Article X of the
Company's By-laws.
SECTION 3.05. Compliance. Neither the Company nor any
----------
Subsidiary is in conflict with, or in default or violation of, (i) any law,
rule, regulation, order, judgment or decree applicable to the Company or
any Subsidiary or by which any property or asset of the Company or any
Subsidiary is bound or affected, or (ii) any note, bond, mortgage,
indenture, contract, agreement, lease, license, permit, franchise or other
instrument or obligation to which the Company or any Subsidiary is a party
or by which the Company or any Subsidiary or any property or asset of the
Company or any Subsidiary is bound or affected, except for any such
conflicts, defaults or violations that would not, individually or in the
aggregate, have a Material Adverse Effect.
SECTION 3.06. SEC Filings; Financial Statements. (a) The
---------------------------------
Company has filed all forms, reports and documents required to be filed by
it with the SEC since December 31, 1993, and has heretofore made available
to Parent, in the form filed with the SEC, (i) its Annual Reports on
Form 10-K for the fiscal years ended December 31, 1992, 1993, and 1994,
(ii) its Quarterly Report on Form 10-Q for the period ended June 30, 1995,
as amended, and (iii) all proxy statements relating to the Company's
meetings of stockholders (whether annual or special) held since January 1,
1993 and (iv) all other forms, reports and other registration statements
(other than Quarterly Reports on Form 10-Q not referred to in clause (ii)
above) filed by the Company with the SEC since January 1, 1993 (the forms,
reports and other documents referred to in clauses (i), (ii), (iii) and
(iv) above being referred to herein, collectively, as the "SEC Reports").
-----------
The SEC Reports (i) were prepared in accordance with the requirements of
the Securities Act of 1933, as amended (the "Securities Act"), and the
--------------
Exchange Act, as the case may be, and the rules and regulations thereunder
and (ii) did not at the time they were filed contain any untrue statement
of a material fact or omit to state a material fact required to be stated
therein or necessary in order to make the statements made therein, in the
light of the circumstances under which they were made, not misleading. No
Subsidiary is required to file any form, report or other document with the
SEC.
(b) Each of the consolidated financial statements (including, in
each case, any notes thereto) contained in the SEC Reports was prepared in
accordance with generally accepted accounting principles applied on a
consistent basis throughout the periods indicated (except as may be
indicated in the notes thereto) and each fairly presented the consolidated
financial position, results of operations and changes in financial position
of the Company and the consolidated Subsidiaries as at the respective dates
thereof and for the respective periods indicated therein except as
otherwise noted
<PAGE>
11
therein (subject, in the case of unaudited statements, to normal and
recurring year-end adjustments which were not and are not expected,
individually or in the aggregate, to have a Material Adverse Effect).
Since December 31, 1994, there has been no material adverse change to any
of the consolidated financial statements (including, in each case, any
notes thereto) contained in the SEC Reports.
SECTION 3.07. Offer Documents; Schedule 14D-9; Schedule 13E-3;
------------------------------------------------
Proxy Statement. Neither the Schedule 14D-9 nor any information supplied
---------------
by the Company for inclusion in the Offer Documents nor the Schedule 13E-3
shall, at the respective times the Schedule 14D-9, the Offer Documents, the
Schedule 13E-3 or any amendments or supplements thereto are filed with the
SEC or are first published, sent or given to stockholders of the Company,
as the case may be, contain any untrue statement of a material fact or omit
to state any material fact required to be stated therein or necessary in
order to make the statements made therein, in the light of the
circumstances under which they are made, not misleading. Neither the proxy
statement to be sent to the stockholders of the Company in connection with
the Stockholders' Meeting (as hereinafter defined) nor the information
statement to be sent to such stockholders, as appropriate (such proxy
statement or information statement, as amended or supplemented, being
referred to herein as the "Proxy Statement"), shall, at the date the Proxy
---------------
Statement (or any amendment or supplement thereto) is first mailed to
stockholders of the Company, at the time of the Stockholders' Meeting and
at the Effective Time, be false or misleading with respect to any material
fact, or omit to state any material fact required to be stated therein or
necessary in order to make the statements made therein, in the light of the
circumstances under which they are made, not misleading or necessary to
correct any statement in any earlier communication with respect to the
solicitation of proxies for the Stockholders' Meeting which shall have
become false or misleading. The Schedule 14D-9 and the Proxy Statement
shall comply in all material respects as to form with the requirements of
the Exchange Act and the rules and regulations thereunder. Notwithstanding
the foregoing, the Company makes no representation or warranty with respect
to any information supplied by Gambro, Parent, Purchaser or any of their
representatives which is contained in any of the foregoing documents.
SECTION 3.08. Brokers. No broker, finder or investment banker
-------
(other than Alex. Brown) is entitled to any brokerage, finder's or other fee
or commission in connection with the Transactions based upon arrangements
made by or on behalf of the Company. The Company has heretofore furnished
to Parent a complete and correct copy of all agreements between the Company
and Alex. Brown pursuant to which such firm would be entitled to any
payment relating to the Transactions.
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF GAMBRO, PARENT AND PURCHASER
--------------------------------------------------------------
Gambro, Parent and Purchaser hereby, jointly and severally,
represent and warrant to the Company that:
SECTION 4.01. Corporate Organization. Each of Gambro, Parent
----------------------
and Purchaser is a corporation duly organized, validly existing and in good
standing under the laws of the Kingdom of Sweden, the State of Colorado and
the State of Tennessee, respectively, and has the requisite power and
authority and all necessary governmental approvals to own, lease and
operate its properties and to
<PAGE>
12
carry on its business as it is now being conducted, except where the
failure to be so organized, existing or in good standing or to have such
power, authority and governmental approvals would not, individually or in
the aggregate, have a material adverse effect on the business or operations
of Gambro, Parent and Purchaser and their respective subsidiaries taken as
a whole.
SECTION 4.02. Authority Relative to this Agreement. Each of
------------------------------------
Gambro, Parent and Purchaser has all necessary corporate power and
authority to execute and deliver this Agreement, to perform its obligations
hereunder and to consummate the Transactions. The execution and delivery
of this Agreement by Gambro, Parent and Purchaser and the consummation by
Gambro, Parent and Purchaser of the Transactions have been duly and validly
authorized by all necessary corporate action, and no other corporate
proceedings on the part of Gambro, Parent or Purchaser are necessary to
authorize this Agreement or to consummate the Transactions (other than,
with respect to the Merger, the filing and recordation of appropriate
merger documents as required by Tennessee Law). This Agreement has been
duly and validly executed and delivered by Gambro, Parent and Purchaser
and, assuming the due authorization, execution and delivery by the Company,
constitutes a legal, valid and binding obligation of each of Gambro, Parent
and Purchaser enforceable against each of Gambro, Parent and Purchaser in
accordance with its terms.
SECTION 4.03. No Conflict; Required Filings and Consents. (a)
------------------------------------------
The execution and delivery of this Agreement by Gambro, Parent and
Purchaser do not, and the performance of this Agreement by Gambro, Parent
and Purchaser will not, (i) conflict with or violate the Charter or By-laws
or similar organizational documents of any of Gambro, Parent or Purchaser,
(ii) conflict with or violate any law, rule, regulation, order, judgment or
decree applicable to Gambro, Parent or Purchaser or by which any property
or asset of any of them is bound or affected, or (iii) result in any breach
of or constitute a default (or an event which with notice or lapse of time
or both would become a default) under, or give to others any rights of
termination, amendment, acceleration or cancellation of, or result in the
creation of a lien or other encumbrance on any property or asset of Gambro,
Parent or Purchaser pursuant to, any note, bond, mortgage, indenture,
contract, agreement, lease, license, permit, franchise or other instrument
or obligation to which Gambro, Parent or Purchaser is a party or by which
Gambro, Parent or Purchaser or any property or asset of any of them is
bound or affected, except for any such breaches, defaults or other
occurrences which would not, individually or in the aggregate, have a
material adverse effect on the business or operations of Gambro, Parent or
Purchaser and their respective subsidiaries taken as a whole.
(b) The execution and delivery of this Agreement by Gambro,
Parent and Purchaser do not, and the performance of this Agreement by
Gambro, Parent and Purchaser will not, require any consent, approval,
authorization or permit of, or filing with or notification to, any
governmental or regulatory authority, domestic or foreign, except (i) for
applicable requirements, if any, of the Exchange Act, Blue Sky Laws and
state takeover laws and filing and recordation of appropriate merger
documents as required by Tennessee Law and (ii) where failure to obtain
such consents, approvals, authorizations or permits, or to make such
filings or notifications, would not prevent or delay consummation of the
Offer or the Merger, or otherwise prevent Gambro, Parent or Purchaser from
performing their respective obligations under this Agreement.
SECTION 4.04. Financing. Parent has, or has commitments from
---------
responsible financial institutions to enable it to borrow, sufficient funds
to permit Purchaser to acquire all the outstanding Shares in the Offer and
the Merger and has provided the Special Committee with copies of any such
commitments.
<PAGE>
13
SECTION 4.05. Offer Documents; Proxy Statement. The Offer
--------------------------------
Documents will not, at the time the Offer Documents are filed with the SEC
or are first published, sent or given to stockholders of the Company, as
the case may be, contain any untrue statement of a material fact or omit to
state any material fact required to be stated therein or necessary in order
to make the statements made therein, in the light of the circumstances
under which they are made, not misleading. The information supplied by
Gambro, Parent or Purchaser for inclusion in the Proxy Statement will not,
on the date the Proxy Statement (or any amendment or supplement thereto) is
first mailed to stockholders of the Company, at the time of the
Stockholders' Meeting and at the Effective Time, contain any statement
which, at such time and in light of the circumstances under which it is
made, is false or misleading with respect to any material fact, or omits to
state any material fact required to be stated therein or necessary in order
to make the statements therein not false or misleading or necessary to
correct any statement in any earlier communication with respect to the
solicitation of proxies for the Stockholders' Meeting which shall have
become false or misleading. Notwithstanding the foregoing, Gambro, Parent
and Purchaser make no representation or warranty with respect to any
information supplied by the Company or any of its representatives which is
contained in any of the foregoing documents or the Offer Documents. The
Offer Documents shall comply in all material respects as to form with the
requirements of the Exchange Act and the rules and regulations thereunder.
SECTION 4.06. Full Disclosure. On the date the Schedule 14D-1
---------------
and the Schedule 13E-3 are first filed with the SEC, at the time of the
Stockholders' Meeting (as defined below) and at the Effective Time, (i) the
Schedule 14D-1 and the Schedule 13E-3 will both comply as to form in all
material respects with the provisions of Sections 14(d), 14(e) and 13(e) of
the Exchange Act and the rules and regulations promulgated under such
Sections 14(d), 14(e) and 13(e), and (ii) the Schedule 14D-1 and the
Schedule 13E-3 will not contain any untrue statement of a material fact or
omit to state any material fact necessary in order to make the statement
made, in the light of the circumstances under which they are made, not
misleading.
SECTION 4.07. Brokers. No broker, finder or investment banker
-------
(other than UBS Securities, Inc.) is entitled to any brokerage, finder's or
other fee or commission in connection with the Transactions based upon
arrangements made by or on behalf of Gambro, Parent or Purchaser.
ARTICLE V
ADDITIONAL AGREEMENTS
---------------------
SECTION 5.01. Stockholders' Meeting. If required by applicable
---------------------
law in order to consummate the Merger, the Company, acting through the
Board upon the unanimous recommendation of the Special Committee, shall, in
accordance with applicable law and the Company's Charter and By-laws,
(i) duly call, give notice of, convene and hold an annual or special
meeting of its stockholders as soon as practicable following consummation
of the Offer for the purpose of considering and taking action on this
Agreement and the Transactions (the "Stockholders' Meeting") and
---------------------
(ii) unless in breach of its fiduciary duties under applicable law as
advised by outside counsel, (A) include in the Proxy Statement the
unanimous recommendation of the Board, acting upon the unanimous
recommendation of the Special Committee, that the stockholders of the
Company approve and adopt this Agreement and the Transactions and (B) use
its reasonable best efforts to obtain such approval and adoption. At the
Stockholders' Meeting, Gambro, Parent and Purchaser shall cause all Shares
then owned by them and their subsidiaries to be voted in favor of the
approval and adoption of this
<PAGE>
14
Agreement and the Transactions.
SECTION 5.02. Proxy Statement. If required by applicable law,
---------------
as promptly as practicable following consummation of the Offer, the Company
shall file the Proxy Statement with the SEC under the Exchange Act and
shall use its reasonable best efforts to have the Proxy Statement cleared
by the SEC. Parent, Purchaser and the Company shall cooperate with each
other in the preparation of the Proxy Statement, and the Company shall
notify Parent of the receipt of any comments of the SEC with respect to the
Proxy Statement and of any requests by the SEC for any amendment or
supplement thereto or for additional information and shall provide to
Parent promptly copies of all correspondence between the Company or any
representative of the Company and the SEC. The Company shall give Parent
and its counsel the opportunity to review the Proxy Statement prior to its
being filed with the SEC and shall give Parent and its counsel the
opportunity to review all amendments and supplements to the Proxy Statement
and all responses to requests for additional information and replies to
comments prior to their being filed with, or sent to, the SEC. Each of the
Company, Gambro, Parent and Purchaser agrees to use its reasonable best
efforts, after consultation with the other parties hereto, to respond
promptly to all such comments of and requests by the SEC and to cause the
Proxy Statement and all required amendments and supplements thereto to be
mailed to the holders of Shares entitled to vote at the Stockholders'
Meeting at the earliest practicable time.
SECTION 5.03. Directors' and Officers' Indemnification and
--------------------------------------------
Insurance. (a) Parent shall cause the Surviving Corporation to keep in
---------
effect the provisions in its Charter and By-laws containing the provisions
with respect to exculpation of director and officer liability and
indemnification set forth in the Charter and By-laws of the Company on the
date of this Agreement to the fullest extent permitted under applicable
law, which provisions shall not be amended, repealed or otherwise modified
except as required by applicable law or except to make changes permitted by
applicable law that would enlarge the exculpation or rights of
indemnification thereunder.
(b) From and after the Effective Time, Gambro and Parent each
hereby agree, jointly and severally, to guarantee and to cause the
Surviving Corporation to perform all of its obligations under the Charter
and By-laws of the Company with respect to indemnification.
(c) To the extent that paragraphs (a) and (b) or the provisions
of the Charter or By-laws of the Surviving Corporation shall not serve to
indemnify and hold harmless each present director and officer of the
Company (the "Indemnified Parties"), after the Effective Time, Gambro and
-------------------
Parent shall, subject to the terms set forth herein, indemnify and hold
harmless, to the fullest extent permitted under applicable law (and shall
also advance expenses as incurred to the fullest extent permitted under
applicable law provided the person to whom expenses are advanced provides
an undertaking to repay such advances if it is ultimately determined that
such person is not entitled to indemnification), each Indemnified Party
against any costs or expenses (including reasonable attorney's fees),
judgments, fines, losses, claims, damages, liabilities and amounts paid in
settlement in connection with any claim, action, suit, proceeding or
investigation, whether civil, criminal, administrative or investigative,
arising out of or pertaining to the Transactions for a period of six years
after the date hereof; provided that, in the event any claim or claims are
--------
asserted or made within such six-year period, all rights to indemnification
in respect of any such claim or claims shall continue until final
disposition of any and all such claims. Any Indemnified Party wishing to
claim indemnification under this paragraph (c), upon learning of any such
claim, action, suit, proceeding or investigation, shall promptly notify
Gambro and Parent thereof, but the failure to so notify shall not relieve
Gambro and Parent of any liability they may have to such Indemnified Party
if such failure does not materially
<PAGE>
15
prejudice the indemnifying party. In the event of any such claim, action,
suit, proceeding or investigation (whether arising before or after the
Effective Time), (i) Gambro, Parent or the Surviving Corporation shall have
the right to assume the defense thereof with competent counsel reasonably
satisfactory to the Indemnified Party and Parent shall not be liable to
such Indemnified Parties for any legal expenses of other counsel
subsequently incurred by such Indemnified Parties in connection with the
defense thereof, except that if Gambro, Parent or the Surviving Corporation
elects not to assume or fails to assume any such defense or there are
issues which raise actual or potential conflicts of interest between
Gambro, Parent and the Surviving Corporation and the Indemnified Parties or
between the Indemnified Parties, the Indemnified Parties may retain counsel
satisfactory to them, and Parent or the Surviving Corporation shall pay all
reasonable fees and expenses of such counsel for the Indemnified Parties
promptly as statements therefor are received; provided, however, that
-------- -------
Parent shall be obligated pursuant to this paragraph (c) to pay for only
one firm of counsel for all Indemnified Parties, and one firm of local
counsel in each jurisdiction, unless the use of one counsel for such
Indemnified Parties would present such counsel with an actual or potential
conflict of interest; (ii) the Indemnified Parties will cooperate in the
defense of any such matter and (iii) Gambro and Parent shall not be liable
for any settlement effected without their prior written consent which
consent shall not be unreasonably withheld; and provided further that
-------- -------
Gambro and Parent shall not have any obligation hereunder to any
Indemnified Party when, if and to the extent a court of competent
jurisdiction shall ultimately determine, and such determination shall have
become final, that the indemnification of such Indemnified Party in the
manner contemplated hereby is prohibited by applicable law. Gambro and
Parent hereby consent to personal jurisdiction, service and venue in any
court in the State of Tennessee for purposes of enforcement of the
foregoing provisions.
(d) Parent shall cause the Surviving Corporation to use its best
efforts to maintain in effect for six years from the Effective Time, if
available, the coverage provided by the current directors' and officers'
liability insurance policies maintained by the Company (provided that the
Surviving Corporation may substitute therefor policies of at least the same
coverage containing terms and conditions which are not materially less
favorable) with respect to matters occurring prior to the Effective Time.
SECTION 5.04. Further Action; Reasonable Best Efforts. Upon the
---------------------------------------
terms and subject to the conditions hereof, each of the parties hereto
shall use its reasonable best efforts to take, or cause to be taken, all
appropriate action, and to do, or cause to be done, all things necessary,
proper or advisable under applicable laws and regulations to consummate and
make effective the Transactions, including, without limitation, using its
reasonable best efforts to obtain all licenses, permits, consents,
approvals, authorizations, qualifications and orders of governmental
authorities and parties to contracts with the Company and the Subsidiaries
as are necessary for the consummation of the Transactions and to fulfill
the conditions to the Offer and the Merger. In case at any time after the
Effective Time any further action is necessary or desirable to carry out
the purposes of this Agreement, the proper officers and directors of each
party to this Agreement shall use their reasonable best efforts to take all
such action.
SECTION 5.05. Public Announcements. Parent and the Company
--------------------
shall consult with each other before issuing any press release or otherwise
making any public statements with respect to this Agreement or any
Transaction and shall not issue any such press release or make any such
public statement prior to such consultation, except as may be required by
law or any listing agreement with a national securities exchange to which
Parent or the Company is a party.
<PAGE>
16
SECTION 5.06. Gambro Guarantee. Gambro hereby guarantees the
----------------
performance by Parent and Purchaser of their agreements and obligations
hereunder and consents to personal jurisdiction, service and venue in any
court in the State of Tennessee for purposes of enforcement of this
provision.
ARTICLE VI
CONDITIONS TO THE MERGER
------------------------
SECTION 6.01. Conditions to the Merger. The respective
------------------------
obligations of each party to effect the Merger shall be subject to the
satisfaction at or prior to the Effective Time of the following conditions:
(a) Stockholder Approval. This Agreement and the
--------------------
transactions contemplated hereby shall have been approved and adopted
by the affirmative vote of the stockholders of the Company to the
extent required by Tennessee Law and the Charter of the Company;
(b) Agreements and Covenants. The parties hereto shall
------------------------
have performed or complied in all material respects with all
agreements and covenants required by this Agreement to be performed or
complied with by them on or prior to the Effective Time;
(c) No Order. No governmental authority or other agency or
--------
commission or court of competent jurisdiction shall have enacted,
issued, promulgated, enforced or entered any law, rule, regulation,
executive order, decree, injunction or other order (whether temporary,
preliminary or permanent) which is then in effect and has the effect
of making the acquisition of Shares by Gambro, Parent or Purchaser or
any affiliate of either of them illegal or otherwise restricting,
preventing or prohibiting consummation of the Transactions; and
(d) Offer. Purchaser or its permitted assignee shall have
-----
purchased all Shares validly tendered and not withdrawn pursuant to
the Offer; provided, however, that this condition shall not be
-------- -------
applicable to the obligations of Gambro, Parent or Purchaser if, in
breach of this Agreement or the terms of the Offer, Purchaser fails to
purchase any Shares validly tendered and not withdrawn pursuant to the
Offer.
ARTICLE VII
TERMINATION, AMENDMENT AND WAIVER
---------------------------------
SECTION 7.01. Termination. This Agreement may be terminated and
-----------
the Merger and the other Transactions may be abandoned at any time prior to
the Effective Time, notwithstanding any requisite approval and adoption of
this Agreement and the transactions contemplated hereby by the stockholders
of the Company:
(a) By mutual written consent of Gambro, Parent, Purchaser
and the Special Committee, acting on behalf of the Company; or
<PAGE>
17
(b) By either Parent, Purchaser or the Special Committee,
acting on behalf of the Company, if (i) the Effective Time shall not
have occurred on or before March 31, 1996; provided, however, that the
-------- -------
right to terminate this Agreement under this Section 7.01(b) shall not
be available to any party whose failure to fulfill any obligation
under this Agreement has been the cause of, or resulted in, the
failure of the Effective Time to occur on or before such date or
(ii) any court of competent jurisdiction or other governmental
authority shall have issued an order, decree or ruling or taken any
other action restraining, enjoining or otherwise prohibiting the
Merger and such order, decree, ruling or other action shall have
become final and nonappealable; or
(c) By Parent if (i) due to an occurrence or circumstance
that would result in a failure to satisfy any condition set forth in
Annex A hereto, Purchaser shall have (A) failed to commence the Offer
within 60 days following the date of this Agreement, (B) terminated
the Offer without having accepted any Shares for payment thereunder or
(C) failed to pay for Shares pursuant to the Offer within 90 days
following the commencement of the Offer, unless such failure to pay
for Shares shall have been caused by or resulted from the failure of
Gambro, Parent or Purchaser to perform in any material respect any
material covenant or agreement of either of them contained in this
Agreement or the material breach by Gambro, Parent or Purchaser of any
material representation or warranty of either of them contained in
this Agreement or (ii) prior to the purchase of Shares pursuant to the
Offer, the Special Committee, acting on behalf of the Company, shall
have withdrawn or modified in a manner adverse to Purchaser or Parent
its approval or recommendation of the Offer, this Agreement, the
Merger or any other Transaction or shall have recommended another
merger, consolidation, business combination with, or acquisition of,
the Company or its assets or another tender offer for Shares, or shall
have resolved to do any of the foregoing; or
(d) By the Special Committee acting on behalf of the
Company, if Purchaser shall have (A) failed to commence the Offer
within 60 days following the date of this Agreement, (B) terminated
the Offer without having accepted any Shares for payment thereunder or
(C) failed to pay for Shares pursuant to the Offer within 90 days
following the commencement of the Offer, unless such failure to pay
for Shares shall have been caused by or resulted from the failure of
the Company to perform in any material respect any material covenant
or agreement of it contained in this Agreement or the material breach
of the Company of any material representation or warranty of it
contained in this Agreement; or
(e) Prior to the purchase of Shares pursuant to the Offer,
by the Special Committee, acting on behalf of the Company, (i) if any
representation or warranty of Gambro, Parent or Purchaser was untrue
or incorrect in any material respect when made and on and as of the
expiration of the Offer, except for changes contemplated by this
Agreement, with the same force and effect as if made on and as of the
date of such expiration, or in the case of a representation or
warranty made or given as of a specified time, if such representation
or warranty was untrue or incorrect in any material respect as of such
time or (ii) if Parent, Purchaser or Gambro has failed to perform or
comply with, in any material respect, any of their covenants and
agreements in this Agreement.
(f) By either Parent, Purchaser or the Special Committee,
acting on behalf of the Company, if the conditions to the Merger set
forth in Section 6.01 are not reasonably capable of being satisfied on
or before March 31, 1996.
<PAGE>
18
SECTION 7.02. Effect of Termination. In the event of the
---------------------
termination of this Agreement pursuant to Section 7.01, this Agreement
shall forthwith become void, and there shall be no liability on the part of
any party hereto, except (i) as set forth in Sections 7.03 and 8.01 and
(ii) nothing herein shall relieve any party from liability for any wilful
breach hereof.
SECTION 7.03. Fees and Expenses. All fees, costs and expenses
-----------------
incurred in connection with this Agreement and the Transactions shall be
paid by the party incurring such fees, costs and expenses, whether or not
any Transaction is consummated, provided, however, that the Purchaser and
-------- -------
the Company shall each pay for one-half of all fees, costs and expenses
incurred in connection with this Agreement and the Transactions which are
payable to the SEC and to any financial or other printer.
SECTION 7.04. Amendment. This Agreement may be amended by the
---------
parties hereto at any time prior to the Effective Time, provided, however,
-------- -------
that the Company can take action to amend this Agreement only with the
consent of the Special Committee and, provided further that, after the
-------- -------
approval and adoption of this Agreement and the transactions contemplated
hereby by the stockholders of the Company, no amendment may be made which
would reduce the amount or change the type of consideration into which each
Share shall be converted upon consummation of the Merger. This Agreement
may not be amended except by an instrument in writing signed by the parties
hereto.
SECTION 7.05. Waiver. At any time prior to the Effective Time,
------
any party hereto may (i) extend the time for the performance of any
obligation or other act of any other party hereto, (ii) waive any
inaccuracy in the representations and warranties contained herein or in any
document delivered pursuant hereto and (iii) waive compliance with any
agreement or condition contained herein. Any such extension or waiver
shall be valid if set forth in an instrument in writing signed by the party
or parties to be bound thereby. Any such extension or waiver by the
Company may be made only by the Special Committee.
ARTICLE VIII
GENERAL PROVISIONS
------------------
SECTION 8.01. Non-Survival of Representations, Warranties and
-----------------------------------------------
Agreements. The representations, warranties and agreements in this
----------
Agreement shall terminate at the Effective Time or upon the termination of
this Agreement pursuant to Section 7.01, as the case may be, except that
the agreements set forth in Article II and Section 5.03 shall survive the
Effective Time indefinitely and those set forth in Section 7.03 shall
survive termination indefinitely.
SECTION 8.02. Notices. All notices, requests, claims, demands
-------
and other communications hereunder shall be in writing and shall be given
(and shall be deemed to have been duly given upon receipt) by delivery in
person, by cable, telecopy, telegram or telex or by registered or certified
mail (postage prepaid, return receipt requested) to the respective parties
at the following addresses (or at such other address for a party as shall
be specified in a notice given in accordance with this Section 8.02):
if to Parent or Purchaser:
<PAGE>
19
Herbert S. Lawson
COBE Laboratories, Inc.
1185 Oak Street
Lakewood, CO 80215-4498
Telecopier No: (303) 231-4915
with a copy to:
Shearman & Sterling
599 Lexington Avenue
New York, New York 10022
Telecopier No: (212) 848-7179/80/81/82
Attention: Peter D. Lyons, Esq.
if to the Company:
J. Kenneth Jacobs, M.D.
Special Committee of the Board of Directors
REN Corporation-USA
6820 Charlotte Pike
Nashville, TN 37209
Telecopier No: (615) 352-1938
and with a copy to:
Ralph Z. Levy, Esq.
REN Corporation-USA
6820 Charlotte Pike
Nashville, TN 37209
Telecopier No: (615) 352-1938
and with a copy to:
Waller, Landsden, Dortch & Davis
Nashville City Center
511 Union Street, Suite 2100
Nashville, TN 37219-1760
Telecopier No: (615) 244-5686
Attention: J. Chase Cole, Esq.
and with a copy to:
Mayer, Brown & Platt
190 S. LaSalle Street
Chicago, IL 60603
Telecopier No: (312) 701-7711
Attention: Scott J. Davis, Esq.
<PAGE>
20
SECTION 8.03 Enforcement of Agreement. Until the Effective
------------------------
Time, the Special Committee shall continue in existence and shall have the
right to cause the Company to take any action necessary to enforce the
rights of the Company and the obligations of Gambro, Parent and Purchaser
under this Agreement.
SECTION 8.04. Certain Definitions. For purposes of this
-------------------
Agreement, the term:
(a) "affiliate" of a specified person means a person who
---------
directly or indirectly through one or more intermediaries controls, is
controlled by, or is under common control with, such specified person;
(b) "beneficial owner" with respect to any Shares means a
----------------
person who shall be deemed to be the beneficial owner of such Shares
(i) which such person or any of its affiliates or associates (as such
term is defined in Rule 12b-2 promulgated under the Exchange Act)
beneficially owns, directly or indirectly, (ii) which such person or
any of its affiliates or associates has, directly or indirectly,
(A) the right to acquire (whether such right is exercisable
immediately or subject only to the passage of time), pursuant to any
agreement, arrangement or understanding or upon the exercise of
conversion rights, exchange rights, warrants or options, or otherwise,
or (B) the right to vote pursuant to any agreement, arrangement or
understanding or (iii) which are beneficially owned, directly or
indirectly, by any other persons with whom such person or any of its
affiliates or associates or person with whom such person or any of its
affiliates or associates has any agreement, arrangement or
understanding for the purpose of acquiring, holding, voting or
disposing of any Shares;
(c) "business day" means any day on which the principal
------------
offices of the SEC in Washington, D.C. are open to accept filings, or,
in the case of determining a date when any payment is due, any day on
which banks are not required or authorized to close in the City of New
York;
(d) "control" (including the terms "controlled by" and
------- -------------
"under common control with") means the possession, directly or
-------------------------
indirectly or as trustee or executor, of the power to direct or cause
the direction of the management and policies of a person, whether
through the ownership of voting securities, as trustee or executor, by
contract or credit arrangement or otherwise;
(e) "person" means an individual, corporation, partnership,
------
limited partnership, syndicate, person (including, without limitation,
a "person" as defined in Section 13(d)(3) of the Exchange Act), trust,
association or entity or government, political subdivision, agency or
instrumentality of a government; and
(f) "subsidiary" or "subsidiaries" of the Company, the
---------- ------------
Surviving Corporation, Gambro, Parent or any other person means an
affiliate controlled by such person, directly or indirectly, through
one or more intermediaries.
SECTION 8.05. Severability. If any term or other provision of
------------
this Agreement is invalid, illegal or incapable of being enforced by any
rule of law, or public policy, all other conditions and provisions of this
Agreement shall nevertheless remain in full force and effect so long as the
economic or legal substance of the Transactions is not affected in any
manner materially adverse to any
<PAGE>
21
party. Upon such determination that any term or other provision is
invalid, illegal or incapable of being enforced, the parties hereto shall
negotiate in good faith to modify this Agreement so as to effect the
original intent of the parties as closely as possible in a mutually
acceptable manner in order that the Transactions be consummated as
originally contemplated to the fullest extent possible.
SECTION 8.06. Entire Agreement; Assignment. This Agreement
----------------------------
constitutes the entire agreement among the parties with respect to the
subject matter hereof and supersedes all prior agreements and undertakings,
both written and oral, among the parties, or any of them, with respect to
the subject matter hereof. This Agreement shall not be assigned by
operation of law or otherwise, except that Gambro, Parent and Purchaser may
assign all or any of their rights and obligations hereunder to any
affiliate of Parent provided that no such assignment shall relieve the
assigning party of its obligations hereunder if such assignee does not
perform such obligations.
SECTION 8.07. Parties in Interest. This Agreement shall be
-------------------
binding upon and inure solely to the benefit of each party hereto, and
nothing in this Agreement, express or implied, is intended to or shall
confer upon any other person any right, benefit or remedy of any nature
whatsoever under or by reason of this Agreement, other than Section 5.03
(which is intended to be for the benefit of the persons covered thereby and
may be enforced by such persons).
SECTION 8.08. Specific Performance. The parties hereto agree
--------------------
that irreparable damage would occur in the event any provision of this
Agreement were not performed in accordance with the terms hereof and that
the parties shall be entitled to specific performance of the terms hereof,
in addition to any other remedy at law or equity.
SECTION 8.09. Governing Law. This Agreement shall be governed
-------------
by, and construed in accordance with, the laws of the State of Tennessee
applicable to contracts executed in and to be performed in that State.
SECTION 8.10. Headings. The descriptive headings contained in
--------
this Agreement are included for convenience of reference only and shall not
affect in any way the meaning or interpretation of this Agreement.
SECTION 8.11. Counterparts. This Agreement may be executed in
------------
one or more counterparts, and by the different parties hereto in separate
counterparts, each of which when executed shall be deemed to be an original
but all of which taken together shall constitute one and the same
agreement.
<PAGE>
22
IN WITNESS WHEREOF, Gambro, Parent, Purchaser and the Company
have caused this Agreement to be executed as of the date first written
above by their respective officers thereunto duly authorized.
GAMBRO AB
By
-------------------------------------
Title:
By
-------------------------------------
Title:
COBE LABORATORIES, INC.
By
-------------------------------------
Title:
REN ACQUISITION CORP.
By
-------------------------------------
Title:
REN CORPORATION-USA
By
-------------------------------------
Title:
<PAGE>
ANNEX A
-------
Conditions to the Offer
-----------------------
Notwithstanding any other provision of the Offer, Purchaser shall
not be required to accept for payment or pay for any Shares tendered
pursuant to the Offer, and may terminate or amend the Offer and may
postpone the acceptance for payment of and payment for Shares tendered, if
the Minimum Condition shall not have been satisfied or at any time on or
after the date of this Agreement, and prior to the acceptance for payment
of Shares, any of the following conditions shall exist:
(a) there shall have been any action taken, or any statute,
rule, regulation, legislation, interpretation, judgment, order or
injunction enacted, entered, enforced, promulgated, amended, issued or
deemed applicable to Parent, the Company or any subsidiary or
affiliate of Gambro, Parent or the Company restraining or prohibiting
the consummation of the Offer or the Merger and that has a Material
Adverse Effect;
(b) (i) the Board, with the consent of the Special
Committee, shall have withdrawn or modified in a manner adverse to
Gambro, Parent or Purchaser the approval or recommendation of the
Offer, the Merger, the Merger Agreement, or approved or recommended
any takeover proposal or any other acquisition of Shares other than
the Offer or the Merger or (ii) the Board, with the consent of the
Special Committee, shall have resolved to do any of the foregoing;
(c) any representation or warranty of the Company in the
Merger Agreement which is qualified as to materiality shall not be
true and correct or any such representation or warranty that is not so
qualified shall not be true and correct in any material respect, in
each case either when made or on and as of the expiration of the
Offer, except for changes contemplated by the Merger Agreement, with
the same force and effect as if made on and as of the expiration of
the Offer, or in the case of a representation or warranty made on or
given as of a specified time, if such representation or warranty was
untrue or incorrect as of such time;
(d) the Company shall have failed to perform in any
material respect any obligation or to comply in any material respect
with any agreement or covenant of the Company to be performed or
complied with by it under the Merger Agreement;
(e) the Merger Agreement shall have been terminated in
accordance with its terms; or
(f) Purchaser and the Company shall, with the consent of
the Special Committee, have agreed that Purchaser shall terminate the
Offer or postpone the acceptance for payment of or payment for Shares
thereunder;
which, in the reasonable judgment of Purchaser in any such case, and
regardless of the circumstances (including any action or inaction by Parent
or any of its affiliates) giving rise to any such condition, makes it
inadvisable to proceed with such acceptance for payment or payment.
<PAGE>
A-2
The foregoing conditions are for the sole benefit of Purchaser
and Parent and may be asserted by Purchaser or Parent regardless of the
circumstances giving rise to any such condition or may be waived by
Purchaser or Parent in whole or in part at any time and from time to time
in their sole discretion; provided, however, that the Minimum Condition may
-------- -------
not be waived except with the prior written consent of the Special
Committee. The failure by Gambro, Parent or Purchaser at any time to
exercise any of the foregoing rights shall not be deemed a waiver of any
such right; the waiver of any such right with respect to particular facts
and other circumstances shall not be deemed a waiver with respect to any
other facts and circumstances; and each such right shall be deemed an
ongoing right that may be asserted at any time and from time to time.
EXHIBIT T
[REN CORPORATION-USA PRESS RELEASE]
FOR IMMEDIATE RELEASE
REN CORPORATION-USA ANNOUNCES SIGNING OF
DEFINITIVE MERGER AGREEMENT
NASHVILLE, Tenn., September 13, 1995 - REN Corporation-USA, a
Tennessee corporation (NASDAQ: RENL), today announced that it has signed a
definitive merger agreement with Gambro AB (NASDAQ: GAMBY) and COBE
Laboratories, Inc., the Lakewood, Colorado-based wholly owned subsidiary of
Gambro ("COBE"), providing for the acquisition of REN's publicly held
shares at a price of $20 per share, net to the seller in cash. Pursuant to
the merger agreement, a newly formed wholly owned subsidiary of COBE
("Purchaser") will commence a tender offer for all of the issued and
outstanding shares of common stock of REN not currently owned by COBE.
Purchaser will commence the tender offer no later than September 19, 1995.
Following the tender offer, Purchaser will be merged into REN, and all REN
shares not purchased pursuant to the tender offer will be converted into a
right to receive $20 per share in cash in a second-step merger to be
consummated as soon as practicable after the tender offer. Upon
consummation of the merger, REN will become a wholly owned subsidiary of
COBE and an indirect wholly owned subsidiary of Gambro.
The tender offer will be conditioned upon, among other things, at
least a majority of the REN shares, other than the REN shares owned by COBE
or its affiliates, being validly tendered and not withdrawn prior to the
expiration of the tender offer. COBE and its affiliates presently own
approximately 53% of the outstanding REN shares.
The merger agreement has been unanimously approved by a special
committee of independent directors of REN and, based on the recommendation
of the special committee, the Board of Directors of REN has unanimously
approved the merger agreement and recommended that holders tender their REN
shares pursuant to the tender offer.
UBS Securities Inc. is acting as financial advisor to COBE in
connection with the transaction and is acting as sole Dealer Manager in
connection with the tender offer.
Alex. Brown & Sons Incorporated is acting as financial advisor to
the special committee and has rendered an opinion that the consideration to
be received by the public shareholders of REN pursuant to the merger
agreement is fair from a financial point of view.
REN is the nation's fourth largest provider of kidney dialysis
services. REN owns and operates 68 dialysis centers, located across 18 states
and the District of Columbia. Several of these centers are associated with
prominent academic institutions. Overall, the company has over 1,150 treatment
stations servicing approximately 5,700 patients. In 1994, REN performed more
than 646,000 dialysis treatments. REN also performs blood and urine testing
services for its centers and others.
